0001398137 false 2021 Q2 --12-31 P5Y P3Y P5Y2M 2020-06-30 2020-04-30 P0Y P5Y P5Y P5Y 0001398137 2021-01-01 2021-06-30 0001398137 2021-08-02 0001398137 2021-06-30 0001398137 2020-12-31 0001398137 2021-04-01 2021-06-30 0001398137 2020-04-01 2020-06-30 0001398137 2020-01-01 2020-06-30 0001398137 us-gaap:CommonStockMember 2021-03-31 0001398137 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001398137 us-gaap:RetainedEarningsMember 2021-03-31 0001398137 2021-03-31 0001398137 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001398137 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001398137 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001398137 us-gaap:CommonStockMember 2021-06-30 0001398137 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001398137 us-gaap:RetainedEarningsMember 2021-06-30 0001398137 us-gaap:CommonStockMember 2020-12-31 0001398137 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001398137 us-gaap:RetainedEarningsMember 2020-12-31 0001398137 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001398137 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001398137 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001398137 us-gaap:CommonStockMember 2020-03-31 0001398137 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001398137 us-gaap:RetainedEarningsMember 2020-03-31 0001398137 2020-03-31 0001398137 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001398137 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001398137 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001398137 us-gaap:CommonStockMember 2020-06-30 0001398137 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001398137 us-gaap:RetainedEarningsMember 2020-06-30 0001398137 2020-06-30 0001398137 us-gaap:CommonStockMember 2019-12-31 0001398137 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001398137 us-gaap:RetainedEarningsMember 2019-12-31 0001398137 2019-12-31 0001398137 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001398137 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0001398137 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0001398137 GNAL:LightingMember GNAL:HydroponicResellersRetailMember 2021-04-01 2021-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember GNAL:HydroponicResellersRetailMember 2021-04-01 2021-06-30 0001398137 GNAL:HydroponicResellersRetailMember 2021-04-01 2021-06-30 0001398137 GNAL:LightingMember GNAL:DirectToConsumerOnlineMember 2021-04-01 2021-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember GNAL:DirectToConsumerOnlineMember 2021-04-01 2021-06-30 0001398137 GNAL:DirectToConsumerOnlineMember 2021-04-01 2021-06-30 0001398137 GNAL:LightingMember 2021-04-01 2021-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember 2021-04-01 2021-06-30 0001398137 GNAL:LightingMember GNAL:HydroponicResellersRetailMember 2020-04-01 2020-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember GNAL:HydroponicResellersRetailMember 2020-04-01 2020-06-30 0001398137 GNAL:HydroponicResellersRetailMember 2020-04-01 2020-06-30 0001398137 GNAL:LightingMember GNAL:DirectToConsumerOnlineMember 2020-04-01 2020-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember GNAL:DirectToConsumerOnlineMember 2020-04-01 2020-06-30 0001398137 GNAL:DirectToConsumerOnlineMember 2020-04-01 2020-06-30 0001398137 GNAL:LightingMember 2020-04-01 2020-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember 2020-04-01 2020-06-30 0001398137 GNAL:LightingMember GNAL:HydroponicResellersRetailMember 2021-01-01 2021-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember GNAL:HydroponicResellersRetailMember 2021-01-01 2021-06-30 0001398137 GNAL:HydroponicResellersRetailMember 2021-01-01 2021-06-30 0001398137 GNAL:LightingMember GNAL:DirectToConsumerOnlineMember 2021-01-01 2021-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember GNAL:DirectToConsumerOnlineMember 2021-01-01 2021-06-30 0001398137 GNAL:DirectToConsumerOnlineMember 2021-01-01 2021-06-30 0001398137 GNAL:LightingMember 2021-01-01 2021-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember 2021-01-01 2021-06-30 0001398137 GNAL:LightingMember GNAL:HydroponicResellersRetailMember 2020-01-01 2020-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember GNAL:HydroponicResellersRetailMember 2020-01-01 2020-06-30 0001398137 GNAL:HydroponicResellersRetailMember 2020-01-01 2020-06-30 0001398137 GNAL:LightingMember GNAL:DirectToConsumerOnlineMember 2020-01-01 2020-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember GNAL:DirectToConsumerOnlineMember 2020-01-01 2020-06-30 0001398137 GNAL:DirectToConsumerOnlineMember 2020-01-01 2020-06-30 0001398137 GNAL:LightingMember 2020-01-01 2020-06-30 0001398137 GNAL:PlantNutrientsAndFertilizersMember 2020-01-01 2020-06-30 0001398137 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001398137 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001398137 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-06-30 0001398137 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-06-30 0001398137 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001398137 us-gaap:ConvertibleDebtSecuritiesMember 2020-01-01 2020-06-30 0001398137 us-gaap:SalesRevenueNetMember GNAL:CustomerOneMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2021-06-30 0001398137 us-gaap:SalesRevenueNetMember GNAL:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2021-06-30 0001398137 us-gaap:SalesRevenueNetMember GNAL:OneCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2020-06-30 0001398137 us-gaap:SalesRevenueNetMember GNAL:OneCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-06-30 0001398137 us-gaap:SalesRevenueNetMember GNAL:CustomerOneMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001398137 us-gaap:SalesRevenueNetMember GNAL:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001398137 us-gaap:SalesRevenueNetMember GNAL:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001398137 us-gaap:SalesRevenueNetMember GNAL:CustomerFourMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001398137 us-gaap:SalesRevenueNetMember GNAL:CustomerFiveMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001398137 country:US srt:MaximumMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2020-04-01 2020-06-30 0001398137 country:US srt:MaximumMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-04-01 2021-06-30 0001398137 country:US srt:MaximumMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-06-30 0001398137 country:US srt:MaximumMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-06-30 0001398137 us-gaap:AccountsReceivableMember GNAL:CustomerOneMember us-gaap:CustomerConcentrationRiskMember 2021-06-28 2021-06-30 0001398137 us-gaap:AccountsReceivableMember GNAL:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember 2021-06-28 2021-06-30 0001398137 us-gaap:AccountsReceivableMember GNAL:CustomerOneMember us-gaap:CustomerConcentrationRiskMember 2020-12-29 2020-12-31 0001398137 us-gaap:AccountsReceivableMember GNAL:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember 2020-12-29 2020-12-31 0001398137 us-gaap:SalesRevenueNetMember GNAL:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember 2020-12-29 2020-12-31 0001398137 GNAL:AcquisitionAgreementMember GNAL:YLKPartnersNVLLCMember 2018-05-31 0001398137 2019-01-01 2019-12-31 0001398137 GNAL:NotesPayableToOfficersShareholdersPastDueMember 2021-06-30 0001398137 GNAL:NotesPayableToOfficersShareholdersPastDueMember 2020-12-31 0001398137 GNAL:NotesPayableToRelatedPartyPastDueMember 2021-06-30 0001398137 GNAL:NotesPayableToRelatedPartyPastDueMember 2020-12-31 0001398137 GNAL:NotesPayableToRelatedPartiesPastDueMember 2021-06-30 0001398137 GNAL:NotesPayableToRelatedPartiesPastDueMember 2020-12-31 0001398137 GNAL:NotesPayableAgreementMember GNAL:MrAlanLienMember 2016-05-08 2016-05-09 0001398137 GNAL:NotesPayableAgreementMember GNAL:MrAlvinHaoMember 2016-05-08 2016-05-09 0001398137 GNAL:NotesPayableAgreementMember GNAL:MrLienMember 2016-05-09 0001398137 GNAL:NotesPayableAgreementMember GNAL:MrHaoMember 2016-05-09 0001398137 GNAL:NotesPayableAgreementMember GNAL:MrAlanLienandMrAlvinHaoMember 2021-06-30 0001398137 GNAL:NotesPayableAgreementMember GNAL:MrAlanLienandMrAlvinHaoMember 2020-12-31 0001398137 GNAL:NotesPayableAgreementMember GNAL:SisterOfAlvinHaoMember 2019-05-07 2019-05-08 0001398137 GNAL:NotesPayableAgreementMember GNAL:SisterOfAlvinHaoMember 2019-05-08 0001398137 GNAL:NotesPayableAgreementMember GNAL:SisterOfAlvinHaoMember 2021-06-30 0001398137 GNAL:NotesPayableAgreementMember GNAL:SisterOfAlvinHaoMember 2020-12-31 0001398137 GNAL:NoteAgreementsMember GNAL:MrLienMember 2021-06-30 0001398137 GNAL:NoteAgreementsMember GNAL:MrLienMember 2021-01-01 2021-06-30 0001398137 GNAL:NoteAgreementsMember GNAL:MrLienMember 2020-12-31 0001398137 GNAL:IndependentPartyMember GNAL:CarsonCaliforniaMember 2019-12-31 0001398137 GNAL:IndependentPartyMember GNAL:CarsonCaliforniaMember 2019-01-01 2019-12-31 0001398137 GNAL:CarsonCaliforniaMember 2021-01-01 2021-06-30 0001398137 GNAL:CarsonCaliforniaMember 2020-01-01 2020-12-31 0001398137 GNAL:UplandCaliforniaMember GNAL:IndependentPartyMember 2020-01-02 0001398137 GNAL:UplandCaliforniaMember GNAL:IndependentPartyMember 2019-12-28 2020-01-02 0001398137 GNAL:UplandCaliforniaMember 2020-12-31 0001398137 GNAL:UplandCaliforniaMember 2021-01-01 2021-06-30 0001398137 GNAL:UplandCaliforniaMember 2021-06-30 0001398137 GNAL:FLMember GNAL:IndependentPartyMember 2021-01-11 0001398137 GNAL:IndependentPartyMember GNAL:FLMember 2021-01-07 2021-01-11 0001398137 GNAL:FLMember GNAL:IndependentPartyMember 2021-01-01 2021-06-30 0001398137 GNAL:FLMember GNAL:IndependentPartyMember 2021-06-30 0001398137 GNAL:FLMember 2021-06-30 0001398137 GNAL:FLMember 2021-01-01 2021-06-30 0001398137 GNAL:MatthewGeschkeMember 2020-06-25 2020-06-26 0001398137 GNAL:MatthewGeschkeMember 2021-06-30 0001398137 GNAL:MatthewGeschkeMember 2020-12-31 0001398137 GNAL:NotesPayableToCelticBankMember 2021-06-30 0001398137 GNAL:NotesPayableToCelticBankMember 2020-12-31 0001398137 GNAL:SBAPaycheckProtectionProgramLoanMember 2021-06-30 0001398137 GNAL:SBAPaycheckProtectionProgramLoanMember 2020-12-31 0001398137 GNAL:SBAEconomicInjuryDisasterLoanMember 2021-06-30 0001398137 GNAL:SBAEconomicInjuryDisasterLoanMember 2020-12-31 0001398137 GNAL:NotesPayableToCelticBankMember GNAL:LoanAgreementMember 2019-05-21 0001398137 GNAL:NotesPayableToCelticBankMember GNAL:LoanAgreementMember 2019-05-20 2019-05-21 0001398137 GNAL:SettlementAgreementMember GNAL:NotesPayableToCelticBankMember 2021-01-01 2021-06-30 0001398137 GNAL:PaycheckProtectionProgramMember 2020-05-06 2020-05-07 0001398137 GNAL:PaycheckProtectionProgramMember 2020-05-07 0001398137 GNAL:PaycheckProtectionProgramMember 2021-06-30 0001398137 GNAL:PaycheckProtectionProgramMember 2020-12-31 0001398137 GNAL:SBAEconomicInjuryDisasterLoanMember 2020-06-05 2020-06-07 0001398137 GNAL:SBAEconomicInjuryDisasterLoanMember 2020-06-07 0001398137 GNAL:EconomicInjuryDisasterLoanMember 2021-06-30 0001398137 GNAL:EconomicInjuryDisasterLoanMember 2020-12-31 0001398137 GNAL:YAIIPNLtdMember 2021-06-30 0001398137 GNAL:YAIIPNLtdMember 2020-12-31 0001398137 GNAL:YAIIPNLtdMember 2018-05-10 0001398137 GNAL:YAIIPNLtdMember 2019-10-29 0001398137 GNAL:YAIIPNLtdMember 2018-05-09 2018-05-10 0001398137 GNAL:YAIIPNLtdMember 2019-10-28 2019-10-29 0001398137 GNAL:YAIIPNLtdMember 2021-01-01 2021-06-30 0001398137 GNAL:YAIIPNLtdMember GNAL:SecuredPromissoryNoteMember us-gaap:WarrantMember 2021-06-30 0001398137 GNAL:YAIIPNLtdMember GNAL:SecuredPromissoryNoteMember GNAL:WarrantOneMember 2021-06-30 0001398137 GNAL:YAIIPNLtdMember GNAL:SecuredPromissoryNoteMember GNAL:WarrantTwoMember 2021-06-30 0001398137 GNAL:YAIIPNLtdMember GNAL:SecuredPromissoryNoteMember GNAL:WarrantThreeMember 2021-06-30 0001398137 GNAL:YAIIPNLtdMember GNAL:SecuredPromissoryNoteMember GNAL:WarrantFourMember 2021-06-30 0001398137 GNAL:YAIIPNLtdMember GNAL:SecuredPromissoryNoteMember 2019-01-01 2019-12-31 0001398137 GNAL:YAIIPNLtdMember GNAL:TwoThousandAndTwentyNoteMember 2020-02-13 0001398137 GNAL:YAIIPNLtdMember GNAL:TwoThousandAndTwentyNoteMember 2020-02-12 2020-02-13 0001398137 2020-02-13 0001398137 GNAL:YAIIPNLtdMember GNAL:SeptemberTwoThousandAndTwentyNoteMember 2020-09-23 0001398137 GNAL:YAIIPNLtdMember GNAL:SeptemberTwoThousandAndTwentyNoteMember 2020-09-22 2020-09-23 0001398137 2020-09-23 0001398137 GNAL:RelatedPartiesMember 2020-12-31 0001398137 GNAL:RelatedPartiesMember 2021-06-30 0001398137 us-gaap:MeasurementInputExercisePriceMember 2021-06-30 0001398137 GNAL:IssuedDuringTwoThousandTwentyOneMember us-gaap:MeasurementInputExercisePriceMember 2021-06-30 0001398137 us-gaap:MeasurementInputExercisePriceMember 2020-12-31 0001398137 us-gaap:MeasurementInputSharePriceMember 2021-06-30 0001398137 GNAL:IssuedDuringTwoThousandTwentyOneMember us-gaap:MeasurementInputSharePriceMember 2021-06-30 0001398137 us-gaap:MeasurementInputSharePriceMember 2020-12-31 0001398137 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-06-30 0001398137 GNAL:IssuedDuringTwoThousandTwentyOneMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-06-30 0001398137 us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-12-31 0001398137 us-gaap:MeasurementInputPriceVolatilityMember 2021-06-30 0001398137 GNAL:IssuedDuringTwoThousandTwentyOneMember us-gaap:MeasurementInputPriceVolatilityMember 2021-06-30 0001398137 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember 2020-12-31 0001398137 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember 2020-12-31 0001398137 us-gaap:MeasurementInputExpectedTermMember 2021-01-01 2021-06-30 0001398137 GNAL:IssuedDuringTwoThousandTwentyOneMember us-gaap:MeasurementInputExpectedTermMember 2021-01-01 2021-06-30 0001398137 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2020-01-01 2020-12-31 0001398137 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2020-01-01 2020-12-31 0001398137 us-gaap:MeasurementInputExpectedDividendRateMember 2021-06-30 0001398137 GNAL:IssuedDuringTwoThousandTwentyOneMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-06-30 0001398137 us-gaap:MeasurementInputExpectedDividendRateMember 2020-12-31 0001398137 GNAL:IssuedDuringTwoThousandTwentyOneMember 2021-06-30 0001398137 srt:DirectorMember 2021-01-01 2021-06-30 0001398137 srt:DirectorMember 2020-01-01 2020-06-30 0001398137 GNAL:YAIIPNLtdAdvisorsGlobalLPMember 2021-01-01 2021-06-30 0001398137 GNAL:YAIIPNLtdAdvisorsGlobalLPMember 2021-06-30 0001398137 GNAL:EmploymentAgreementMember GNAL:MrDavisMember 2020-12-30 2021-01-02 0001398137 GNAL:EmploymentAgreementMember GNAL:MrDavisMember 2021-01-01 2021-06-30 0001398137 GNAL:EmploymentAgreementMember GNAL:MrDavisMember 2021-06-30 0001398137 GNAL:ExercisePriceOneMember srt:MinimumMember 2021-01-01 2021-06-30 0001398137 GNAL:ExercisePriceOneMember srt:MaximumMember 2021-01-01 2021-06-30 0001398137 GNAL:ExercisePriceOneMember 2021-06-30 0001398137 GNAL:ExercisePriceOneMember 2021-01-01 2021-06-30 0001398137 GNAL:ExercisePriceTwoMember 2021-01-01 2021-06-30 0001398137 GNAL:ExercisePriceTwoMember 2021-06-30 0001398137 GNAL:ExercisePriceThreeMember 2021-01-01 2021-06-30 0001398137 GNAL:ExercisePriceThreeMember 2021-06-30 0001398137 GNAL:WarrantOneMember 2021-01-01 2021-06-30 0001398137 GNAL:WarrantOneMember 2021-06-30 0001398137 GNAL:WarrantTwoMember 2021-01-01 2021-06-30 0001398137 GNAL:WarrantTwoMember 2021-06-30 0001398137 GNAL:WarrantThreeMember 2021-01-01 2021-06-30 0001398137 GNAL:WarrantThreeMember 2021-06-30 0001398137 GNAL:WarrantFourMember 2021-01-01 2021-06-30 0001398137 GNAL:WarrantFourMember 2021-06-30 0001398137 us-gaap:WarrantMember 2021-06-30 0001398137 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001398137 us-gaap:WarrantMember 2021-06-30 0001398137 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001398137 us-gaap:MeasurementInputOptionVolatilityMember 2021-06-30 0001398137 us-gaap:MeasurementInputExpectedTermMember 2021-06-30 0001398137 us-gaap:WarrantMember 2020-01-01 2020-12-31 0001398137 GNAL:SettlementAgreementMember GNAL:SichenziaRossFerenceLLPMember 2021-03-30 0001398137 GNAL:SettlementAgreementMember GNAL:SichenziaRossFerenceLLPMember 2021-03-26 2021-03-30 0001398137 GNAL:SettlementAgreementMember 2021-03-26 2021-03-30 0001398137 GNAL:SettlementAgreementMember GNAL:SichenziaRossFerenceLLPMember 2021-06-30 0001398137 GNAL:SettlementAgreementMember GNAL:SichenziaRossFerenceLLPMember 2021-01-01 2021-06-30 0001398137 GNAL:TechnologyLicenseAgreementMember GNAL:ThirdPartyVendorMember 2021-01-01 2021-06-30 0001398137 GNAL:TechnologyLicenseAgreementMember GNAL:ThirdPartyVendorMember 2021-04-01 2021-06-30 0001398137 GNAL:TechnologyLicenseAgreementMember GNAL:ThirdPartyVendorMember 2020-04-01 2020-06-30 0001398137 GNAL:TechnologyLicenseAgreementMember GNAL:ThirdPartyVendorMember 2020-01-01 2020-06-30 0001398137 GNAL:AmendedAgreementMember 2021-06-30 0001398137 GNAL:AmendedAgreementMember 2020-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft GNAL:Integer GNAL:Segment

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

~~[X]~~☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: ~~MARCH~~JUNE 3130, 2021

[☐ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 000-53635

GENERATION ALPHA, INC.

(Exact name of registrant as specified in its charter)

Nevada		20-8609439
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

1689-A Arrow Route

Upland, California 91786

(Address of principal executive offices) (Zip code)

(888) 998-8881

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Ticker symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ~~[X]~~ ☒ No ~~[ ]~~☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ~~[X]~~ ☒ No ~~[ ]~~☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [☐ ] Accelerated filer [☐ ] Non-accelerated filer ~~[X]~~☒ Smaller reporting company ~~[X]~~☒ Emerging growth company ~~[ ]~~☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ~~[ ]~~☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ~~[ ] No~~ ~~[X]~~☐ No ☒

The number of shares of registrant’s common stock outstanding as of ~~May~~August 112, 2021 was 60,~~029~~610,~~830~~253.

GENERATION ALPHA, INC.

INDEX

PART I.	FINANCIAL INFORMATION
	ITEM 1.	Financial Statements
		Condensed Consolidated Balance Sheets as of March 31, 2021 and December 31, 2020	2
		Condensed Consolidated Balance Sheets as of June 30, 2021 and December 31, 2020	2
		Condensed Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020	3
		Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2021 and 2020	3
		Condensed Consolidated Statements of Stockholders’ Deficit for the three months ended March 31, 2021 and 2020	4
		Condensed Consolidated Statements of Stockholders’ Deficit for the three and six months ended June 30, 2021 and 2020	4
		Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2021 and 2020	5
		Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2021 and 2020	5
		Notes to Condensed Consolidated Financial Statements	6
	ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
	ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk	2324
	ITEM 4.	Controls and Procedures	2324
PART II.	OTHER INFORMATION
	ITEM 1.	Legal Proceedings	2526
	ITEM 1A.	Risk Factors	2526
	ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2526
	ITEM 3.	Defaults Upon Senior Securities	2526
	ITEM 4.	Mine Safety Disclosures	2526
	ITEM 5.	Other Information	2526
	ITEM 6.	Exhibits	2526
	SIGNATURES		2627

PART I - FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements.

GENERATION ALPHA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

	March 31, 2021			December 31, 2020
	June 30, 2021			December 31, 2020
ASSETS
Current Assets
Cash	$	~~345~~273,000		$	372,000
Accounts receivable, net of allowance for doubtful accounts and returns of $10,000 and $12,000, respectively		114,000			54,000
Accounts receivable, net of allowance of $5,000 and $12,000, respectively		107,000			54,000
Inventories, net of reserves of $45,000 and $30,000, respectively		99,000			133,000
Inventories, net of reserves of $24,000 and $30,000, respectively		85,000			133,000
Prepaid expenses and other current assets		328,000			54,000
Total Current Assets		~~561~~493,000			613,000
Property and equipment, net		4441,000			15,000
Right of use asset, net		~~225~~212,000			63,000
Other assets		21,000			11,000
Total Assets	$	~~851~~767,000		$	702,000
LIABILITIES AND SHAREHOLDERS’ DEFICIT
Current Liabilities
Accounts payable and accrued expenses	$	1,~~597~~464,000		$	1,649,000
Legal obligations payable		448,000			448,000
Legal settlement payable		448,000			448,000
Lease payable, current portion		380,000			440,000
Lease liabilities, current portion		424,000			440,000
Contract obligations – past due		~~820~~824,000			816,000
Notes payable - related parties – past due		790,000			790,000
Convertible notes payable to related party (including $2,125,000 and $1,775,000 that are past due, respectively), net of discount of $37,000 and $220,000, respectively		2,238,000			2,055,000
Convertible notes payable to related party (including $2,125,000 and $1,775,000 that are past due, respectively), net of discount of $12,000 and $220,000, respectively		2,263,000			2,055,000
Accrued interest to related parties		~~590~~649,000			531,000
Derivative liabilities		2,886,000			2,161,000
Loans payable		-			11,000
Total Current Liabilities		69,~~863~~748,000			68,~~740~~901,000
Lease payable, net of current portion		411,000			182,000
Lease liabilities, net of current portion		355,000			182,000
Loans payable		355,000			355,000
Derivative liabilities		3,598,000			2,161,000
Total Liabilities		10,458,000			9,438,000
Total Liabilities		11,227,000			9,438,000
Commitments and Contingencies		-			-
Commitments and Contingencies
Shareholders’ Deficit
Preferred stock, no par value, 20,000,000 shares authorized; no shares issued and outstanding at March 31, 2021 and December 31, 2020		-			-
Preferred stock, no par value, 20,000,000 shares authorized; no shares issued and outstanding at June 30, 2021 and December 31, 2020		-			-
Common stock, $0.001 par value, 100,000,000 shares authorized; 60,029,830 and 59,557,830 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively		59,000			59,000
Common stock, $0.001 par value, 100,000,000 shares authorized; 60,610,253 and 59,557,830 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively		60,000			59,000
Additional paid-in-capital		32,~~409~~441,000			32,186,000
Accumulated deficit		(42,~~844~~192,000	)		(40,981,000	)
Total Shareholders’ Deficit		(109,~~376~~691,000	)		(8,736,000	)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$	~~851~~767,000		$	702,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

GENERATION ALPHA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(~~Unaudited~~UNAUDITED)

	Three months ended March 31,
	2021			2020			2021			2020
	2021			2020
	Three months ended June 30,						Six months ended June 30,
Sales	$	454,000		$	307,000
	2021			2020			2021			2020
Cost of goods sold		227,000			195,000
Sales	$	463,000		$	276,000		$	917,000		$	583,000
Gross profit		227,000			112,000
Cost of goods sold		141,000			134,000			368,000			329,000
Operating expenses
Gross profit		322,000			142,000			549,000			254,000
Selling, general and administrative expenses		266,000			361,000
Operating expenses
Research and development		26,000			25,000
Selling, general and administrative expenses		303,000			260,000			569,000			621,000
Impairment of right of use asset		-			82,000
Research and development		25,000			25,000			51,000			50,000
Total operating expenses		292,000			468,000
Legal settlement		-			448,000			-			448,000
Loss from operations		(65,000	)		(356,000	)
Impairment of right of use asset		-			-			-			82,000
Other expenses
Total operating expenses		328,000			733,000			620,000			1,201,000
Financing costs (1)		-			(15,000	)
Loss from operations		(6,000	)		(591,000	)		(71,000	)		(947,000	)
Loss on settlement of trade vendor payable		(106,000	)		-
Other income (expenses)
Gain on extinguishment of debt		2,000			-
Gain (loss) on settlement of trade accounts payable		46,000			-			(60,000	)		-
Change in fair value of derivative liability		(1,437,000	)		(942,000	)
Gain on extinguishment of debt		-			-			2,000			-
Interest expense (2)		(257,000	)		(325,000	)
Financing costs (1)		-			-			-			(15,000	)
Total other expenses		(1,798,000	)		(1,282,000	)
Change in fair value of derivative liability		712,000			(583,000	)		(725,000	)		(1,525,000	)
Net loss	$	(1,863,000	)	$	(1,638,000	)
Interest expense (2)		(100,000	)		(246,000	)		(357,000	)		(571,000	)
BASIC AND DILUTED LOSS PER SHARE	$	(0.03	)	$	(0.03	)
Total other income (expenses)		658,000			(829,000	)		(1,140,000	)		(2,111,000	)
WEIGHTED - AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED		59,557,830			48,715,236
Income (loss) before income taxes		652,000			(1,420,000	)		(1,211,000	)		(3,058,000	)
(1) Included in financing costs are these amounts from a related party	$	-		$	15,000
Provision for income taxes		-			-			-			-
(2) Included in interest expense are these amounts from related parties	$	249,000		$	207,000
Net loss	$	652,000		$	(1,420,000	)	$	(1,211,000	)	$	(3,058,000	)
BASIC AND DILUTED LOSS PER SHARE	$	0.00		$	(0.03	)	$	(0.02	)	$	(0.06	)
WEIGHTED - AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED		204,282,307			51,162,447			59,557,830			50,216,412

The accompanying notes are an integral part of these condensed consolidated financial statements.

(1)	Included in financing costs are these amounts from a related party		$	-			$	-			$	-			$	15,000
(2)	Included in interest expense are these amounts from related parties		$	96,000			$	128,000			$	345,000			$	330,000

GENERATION ALPHA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ DEFICIT

(Unaudited)

Three months ended ~~March~~June 3130, 2021

	Shares		Amount		Capital		Deficit			Total
					Additional
	Common Stock				Paid-in		Accumulated
	Shares		Amount		Capital		Deficit			Total
Balance, December 31, 2020		59,557,830	$	59,000	$	32,186,000	$	(40,981,000	)	$	(8,736,000	)
Balance, March 31, 2021(Unaudited)		60,029,830	$	59,000	$	32,409,000	$	(42,844,000	)	$	(10,376,000	)
Fair value of common stock issued to directors		472,000		-		20,000		-			20,000
Common shares issued on conversion of accrued interest on note payable
Fair value of warrants issued in settlement of trade vendor payable		-		-		191,000		-			191,000
Common shares issued on conversion of accrued interest on note payable, shares
Fair value of vested stock options		-		-		12,000		-			12,000
Fair value of common stock issued to directors		580,423		1,000		19,000					20,000
Net loss		-		-		-		(1,863,000	)		(1,863,000	)
Warrants issued in settlement of vendor payable
Balance, March 31, 2021		60,029,830	$	59,000	$	32,409,000	$	(42,844,000	)	$	(10,376,000	)
Fair value of vested stock options						13,000					13,000
Net income								652,000			652,000
Balance, June 30, 2021 (Unaudited)		60,610,253	$	60,000	$	32,441,000	$	(42,192,000	)	$	(9,691,000	)

~~Three~~Six months ended ~~March~~June 3130, ~~2020~~2021

					Additional
	Common Stock				Paid-in		Accumulated
	Shares		Amount		Capital		Deficit			Total
Balance, December 31, 2019		46,820,564	$	47,000	$	31,739,000	$	(40,410,000	)	$	(8,624,000	)
Balance, December 31, 2020		59,557,830	$	59,000	$	32,186,000	$	(40,981,000	)	$	(8,736,000	)
Common shares issued on conversion of accrued interest on note payable		2,287,066		2,000		27,000		-			29,000
Fair value of common stock issued to directors		1,052,423		1,000		39,000					40,000
Fair value of common stock issued to directors		2,166,667		2,000		21,000		-			23,000
Warrants issued in settlement of vendor payable						191,000					191,000
Fair value of vested stock options		-		-		2125,000		-			2125,000
Net loss		-		-		-		(1,~~638~~211,000	)		(1,~~638~~211,000	)
Balance, March 31, 2020		51,274,297	$	51,000	$	31,808,000	$	(42,048,000	)	$	(10,189,000	)
Balance, June 30, 2021 (Unaudited)		60,610,253	$	60,000	$	32,441,000	$	(42,192,000	)	$	(9,691,000	)

~~The~~ Three ~~accompanying~~months ~~notes~~ended ~~are~~June an30, ~~integral part of these condensed consolidated financial statements.~~2020

					Additional
	Common Stock				Paid-in		Accumulated
	Shares		Amount		Capital		Deficit			Total

Balance, March 31, 2020 (Unaudited)		51,274,297	$	51,000	$	31,808,000	$	(42,048,000	)	$	(10,189,000	)

Fair value of common stock issued to directors		464,623		1,000		28,000					29,000

Fair value of vested stock options						25,000					25,000

Net loss								(1,420,000	)		(1,420,000	)

Balance, June 30, 2020 (Unaudited)		51,738,920	$	52,000	$	31,861,000	$	(43,468,000	)	$	(11,555,000	)

Six months ended June 30, 2020

					Additional
	Common Stock				Paid-in		Accumulated
	Shares		Amount		Capital		Deficit			Total

Balance, December 31, 2019		46,820,564	$	47,000	$	31,739,000	$	(40,410,000	)	$	(8,624,000	)

Common shares issued on conversion of accrued interest on note payable		2,287,066		2,000		27,000					29,000

Fair value of common stock issued to directors		2,631,290		3,000		49,000					52,000

Fair value of vested stock options						46,000					46,000

Net loss								(3,058,000	)		(3,058,000	)
Net income (loss)								(3,058,000	)		(3,058,000	)

Balance, June 30, 2020 (Unaudited)		51,738,920	$	52,000	$	31,861,000	$	(43,468,000	)	$	(11,555,000	)

GENERATIONAL ALPHA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(~~Unaudited~~UNAUDITED)

	Three Month Ended March 31,
	2021			2020
	Six Month Ended June 30,
	2021			2020
Cash Flows from Operating Activities
Net loss	$	(1,~~863~~211,000	)	$	(13,~~638~~058,000	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Adjustments to reconcile net loss to net cash used in operating activities
Provision for allowance for doubtful accounts and sales returns		(2,000	)		(65,000	)
Provision for allowance for doubtful accounts		(7,000	)		(96,000	)
Provision for inventory reserves		15(6,000	)		10(4,000	)
Depreciation		3,000			2,000
Depreciation and amortization		6,000			4,000
Amortization of right of use asset		1124,000			612,000
Impairment of right of use asset		-			82,000
Imputed interest contract obligation		48,000			48,000
Amortization of discount on convertible notes payable		183,000			146,000
Amortization on convertible notes payable		208,000			216,000
Fair value of vested stock options		1225,000			2146,000
Fair value of common stock issued to directors		2040,000			2352,000
Financing costs		-			15,000
Loss on settlement of trade vendor payable		106,000			-
Loss on settlement of trade accounts payable		60,000			-
Gain on settlement of a debt		(2,000	)		-
Gain on settlement of debt		(2,000	)
Change in the fair value of derivative liability		1725,~~437,~~000			~~942~~1,525,000
Changes in Assets and Liabilities
(Increase) Decrease in:
Accounts receivable		(5846,000	)		~~(16~~49,000	)
Legal settlements payable		-			142,000
Inventories		54,000			180,000
Inventories		19,000			77,000
Prepaid expenses and other		26,000			(8,000	)
Prepaid expenses and other		51,000			15,000
Other assets		(10,000	)		(1,000	)
(Decrease) Increase in:
Accounts payable and accrued expenses		33(54,000	)		~~182~~104,000
Lease payable		(4,000	)		(4,000	)
Legal settlements payable		-			679,000
Accrued interest to related parties		59,000			44,000
Lease liabilities		(16,000	)		(10,000	)
Net cash provided by (used in) operating activities		14,000			(13,000	)
Accrued interest to related parties		118,000			94,000
Net cash used in operating activities		(58,000	)		(111,000	)
Cash Flows from Investing Activities
Purchase of property and equipment		(32,000	)		-
Net cash used in investing activities		(32,000	)		-
Cash Flows from Financing Activities
Proceeds from convertible notes payable related party, net of fees		-			125,000
Payments on loans payable		(9,000	)		(23,000	)
Proceeds from loans payable		-			355,000
Net cash (used in) provided by financing activities		(9,000	)		102,000
Payments on loans payable		(9,000	)		(26,000	)
Net increase (decrease) in cash		(27,000	)		89,000
Net cash (used in) provided by financing activities		(9,000	)		454,000
Net increase (decrease) in cash		(99,000	)		343,000
Cash beginning of period		372,000			104,000
Cash end of period	$	~~345~~273,000		$	~~193~~447,000
Interest paid	$	1315,000		$	1342,000
Taxes paid	$	-		$	-
Non-Cash Financing Activities
Recording of right to use asset and lease liability	$	173,000		$	89,000
Warrants issued on settlement of trade vendor payable	$	191,000		$	-
Conversion of accrued interest to related parties for common stock	$	-		$	29,000
Derivative liability recorded as a valuation discount	$	-		$	140,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

GENERATION ALPHA, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED ~~MARCH~~JUNE 3130, 2021 AND 2020

(Unaudited)

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

History and Organization

Generation Alpha, Inc. (the “Company”) was originally incorporated under the laws of the State of Nevada on March 2, 2007 as Cinjet, Inc. (“Cinjet”). Effective September 1, 2015, Cinjet changed its corporate name to Solis Tek Inc. (“Solis Tek”). Effective September 25, 2018, Solis Tek changed its corporate name to Generation Alpha, Inc. Effective September 25, 2018, Generation Alpha, Inc. (f/k/a Solis Tek Inc.) (the “Company”) entered into an agreement and plan of merger (the “Merger Agreement”), whereby a wholly-owned subsidiary of the Company (the “Merger Sub”) was merged into the Company (the “Merger”). Upon consummation of the Merger, the separate existence of Merger Sub ceased. On June 23, 2015, the Company entered into an Agreement of Merger and Plan of Reorganization (the “Agreement”) with Solis Tek Inc., a California corporation (“STI”), and CJA Acquisition Corp., a California corporation and a wholly owned subsidiary of the Company (“Merger Sub”), providing for the merger of Merger Sub with and into STI (the “Merger”), with STI surviving the Merger as a wholly-owned subsidiary of the Company. The Merger was accounted for as a recapitalization of the Company with STI being deemed the accounting acquirer.

Overview of Business

The Company is a vertically integrated technology innovator, developer, manufacturer, and distributor focused on bringing products and solutions to commercial and retail cannabis growers in both the medical and adult use recreational space in legal markets across the U.S. The Company’s lighting and nutrient customers include retail stores, distributors and commercial growers in the United States and abroad.

COVID-19 Considerations

During the ~~three~~six months ended ~~March~~June 3130, 2021, the COVID-19 pandemic did not have a material net impact on our operating results. In the future, the pandemic may cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products. The Company has not observed any material impairments of its assets or a significant change in the fair value of its assets due to the COVID-19 pandemic.

Our ability to operate without significant negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the onset of the COVID-19 pandemic, we maintained the consistency of our operations. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.

Going Concern

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the ~~three~~six months ended ~~March~~June 3130, 2021, the Company incurred a net loss of $1,~~863~~211,000 and had a shareholders’ ~~deficit~~ deficit of $109,~~376~~691,000 as of ~~March~~June 3130, 2021. In addition, $23,~~915~~065,000 of notes payable to related parties, $~~590~~649,000 of accrued interest to related parties, and $~~820~~824,000 of contract obligations are past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the financial statements being issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2020 financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

At ~~March~~June 3130, 2021, the Company had cash on hand in the amount of $~~345~~273,000. Management estimates that the current funds on hand will be sufficient to continue operations through ~~December~~March 31, ~~2021~~2022. The continuation of the Company as a going concern is dependent upon its ability to ~~obtain~~ obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. No assurance can be given ~~that~~ that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case orof equity financing.

Basis of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: STI; Solis Tek East, Corporation (“STE”), an entity incorporated under the laws of the State of New Jersey, Zelda Horticulture, Inc. (“Zelda”), an entity incorporated under the laws of the State of California, and YLK Partners NV, LLC (“YLK”), Generation Alpha Brands, Inc., Trilogy Dispensaries, Inc., Extracting Point, LLC (“Extracting Point”), and GrowPro Solutions, Inc., all entities formed under the laws of Nevada. Intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in valuing our allowances for doubtful accounts, reserves for inventory obsolescence, valuing derivative liabilities, valuing equity instruments issued for services, and valuation allowance for deferred tax assets, among others. Actual results could differ from these estimates.

Revenue Recognition

The Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”). This standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services.

Under this guidance, revenue is recognized when control of promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and cost of sales are recognized once products are delivered to the customer’s control and performance obligations are satisfied.

All products sold by the Company are distinct individual products and consist of advanced energy efficient indoor horticulture lighting, plant nutrient products, and ancillary equipment. The products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time.

The Company does not offer a general right of return on any of its sales and considers all sales as final. The Company generally provides a three-year warranty on its ballasts. However, the Company does not maintain a warranty reserve as the Company is able to chargeback its vendors for all warranty claims. As of ~~March~~June 3130, 2021 and December 31, 2020, the Company determined that no reserves for returned product were necessary.

In the following table, revenue is disaggregated by major product line for three months ended ~~March~~June 3130, 2021:

Sales Channels	Lighting		Plant Nutrients and Fertilizers		Total
Hydroponic resellers/retail	$	142,000	$	312,000	$	454,000
Direct to consumer/online		-		-		-
Total	$	142,000	$	312,000	$	454,000

SCHEDULE OF DISAGGREGATED REVENUE

In the following table, revenue is disaggregated by major product line for three months ended March 31, 2020:

Sales Channels	Lighting		Plant Nutrients and Fertilizers		Total

Hydroponic resellers/retail	$	58,000	$	405,000	$	463,000
Direct to consumer/online		-		-		-
Total	$	58,000	$	405,000	$	463,000

Sales Channels	Lighting		Plant Nutrients and Fertilizers		Total
Hydroponic resellers/retail	$	127,000	$	175,000	$	302,000
Direct to consumer/online		5,000		-		5,000
Total	$	132,000	$	175,000	$	307,000

In the following table, revenue is disaggregated by major product line for three months ended June 30, 2020:

Accounts Receivable

Sales Channels	Lighting		Plant Nutrients and Fertilizers		Total

Hydroponic resellers/retail	$	57,000	$	213,000	$	270,000
Direct to consumer/online		6,000		-		6,000
Total	$	63,000	$	213,000	$	276,000

~~Accounts receivable are recorded net of an allowance for expected losses. The Company evaluates the collectability of its trade accounts receivable based on a number of factors.~~ In ~~circumstances where the Company becomes aware of a specific customer’s inability to meet its financial~~ ~~obligations to~~ the ~~Company~~following table, arevenue ~~specific reserve for bad debts~~ is ~~estimated~~disaggregated ~~and~~by ~~recorded,~~major ~~which~~product ~~reduces~~line ~~the~~for ~~recognized~~six ~~receivable~~months toended ~~the estimated~~June ~~amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts~~30, ~~bad debt charges are recorded based on the Company’s historical losses and an overall assessment of past due trade accounts receivable outstanding.~~2021:

The allowance for doubtful accounts and returns is established through a provision reducing the carrying value of receivables. At March 31, 2021 and December 31, 2020, the allowance for doubtful accounts was $10,000 and $12,000, respectively.

Sales Channels	Lighting		Plant Nutrients and Fertilizers		Total

Hydroponic resellers/retail	$	195,000	$	717,000	$	912,000
Direct to consumer/online		5,000		-		5,000
Total	$	200,000	$	717,000	$	917,000

~~Inventories~~In the following table, revenue is disaggregated by major product line for six months ended June 30, 2020:

Inventories are stated at the lower of cost or net realizable value. Cost is computed on a first-in, first-out basis. The Company’s inventories consist almost entirely of finished goods as of March 31, 2021 and December 31, 2020.

Sales Channels	Lighting		Plant Nutrients and Fertilizers		Total

Hydroponic resellers/retail	$	184,000	$	388,000	$	572,000
Direct to consumer/online		11,000		-		11,000
Total	$	195,000	$	388,000	$	583,000

The Company provides inventory reserves based on excess and obsolete inventories determined primarily by future demand forecasts. The write down amount is measured as the difference between the cost of the inventory and net realizable value based on upon assumptions about future demand and charged to the provision for inventory write down, which is a component of cost of sales. At the point of the loss recognition, a new, lower cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. At March 31, 2021 and December 31, 2020, the reserve for excess and obsolete inventory was $45,000 and $30,000, respectively.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Research and Development

Research and development costs are expensed in the period incurred. The costs primarily consist of personnel and supplies.

Shipping and Handling Costs

The Company’s shipping and handling costs relating to inbound freight are reported as cost of goods sold in the consolidated Statements of Operations, while shipping and handling costs relating to outbound freight are reported as selling, general and administrative expenses in the consolidated Statements of Operations. The Company classifies amounts billed to customers for shipping fees as revenues.

Fair Value Measurements

The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:

	●	Level 1 — Quoted prices in active markets for identical assets or liabilities.

	●	Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

	●	Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amounts of financial instruments such as cash, accounts receivable, inventories, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of notes payable approximate their fair values due to the fact that the interest rates on these obligations are based on prevailing market interest rates.

The fair value of the derivative liabilities of $32,~~598~~886,000 and $2,161,000 at ~~March~~June 3130, 2021 and December 31, 2020, respectively, was valued using Level 2 inputs.

Loss per Share Calculations

Basic earnings per share are computed by dividing net income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period.

For the ~~three~~six months ended ~~March~~June 3130, 2021, options to acquire 10,~~262~~709,~~627~~056 shares of common stock, warrants to acquire 32,283,140 shares of ~~common~~ common stock, and 70101,~~033~~732,~~903~~281 shares to be issued upon conversion of our convertible notes have been excluded from the calculation of ~~weighted~~ weighted average common shares, as their effect would have been anti-dilutive. For the ~~three~~six months ended ~~March~~June 3130, 2020, options to acquire 45,~~433~~995,~~300~~ 800 shares of common stock, warrants to acquire 21,283,140 shares of common stock, and ~~267~~187,~~089~~773,~~041~~607 shares to be issued upon conversion of our convertible notes have been excluded from the calculation of weighted average common shares, as their effect would have been anti-dilutive.

Concentration Risks

Cash includes cash on hand and cash in banks and are reported as “Cash” in the consolidated balance sheets. At ~~March~~June 3130, 2021 ~~and~~ and December 31, 2020, cash includes cash on hand of $~~255~~165,000 and $289,000, respectively, and cash in banks of $90108,000 and $83,000, respectively. The balance of cash on hand is not insured by the Federal Deposit Insurance Corporation. The balance of cash in banks is insured by the Federal Deposit Insurance Corporation for up to $250,000.

The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact the Company’s operating results. State and federal government laws could have a material adverse impact on the Company’s future revenues and results of operations.

The Company’s products require specific components that currently are available from a limited number of sources. The Company purchases some of its key products and components from single vendors. During the ~~three~~six months ended ~~March~~June 3130, 2021 and 2020, its ballasts, lamps, and reflectors, which comprised the ~~clear~~ majority of the Company’s purchases during those periods, were each only purchased from ~~one~~ one separate vendor.

~~The~~Two ~~Company~~customers ~~performs~~accounted afor ~~regular~~29% ~~review~~and 18% of ~~customer~~the ~~activity~~Company’s ~~and~~revenue ~~associated~~for ~~credit~~the ~~risks~~three months ended June 30, 2021, and ~~does~~one ~~not~~customer ~~require~~accounted for ~~collateral~~16% orof ~~other~~the ~~arrangements~~Company’s revenue for the three months ended June 30, 2020. One customer accounted for 1221% of the Company’s revenue for the ~~three~~six months ended ~~March~~June 3130, 2021, and ~~one~~five ~~customer~~customers accounted for 30 24%, 15%, 11%, 11%, and 11% of the Company’s revenue for the ~~three~~six months ended ~~March~~June 3130, 2020. There were no other customers that accounted for more than 10% of the Company’s revenue. Shipments to customers outside the United States comprised less than 5% of our sales for the three and six months ended ~~March~~June 3130, 2021 and 2020~~, respectively~~.

As of ~~March~~June 3130, 2021, ~~three~~two customers accounted for 3376%, ~~24%,~~ and 1211% of the Company’s trade accounts receivable balance, and as of ~~December~~ December 31, 2020, three customers accounted for 37%, 23%, and 15% of the Company’s trade accounts receivable balance.

Segment Reporting

The Company operates in one segment for the manufacture and distribution of its products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying consolidated financial statements.

Reclassification

In presenting the Company’s consolidated balance sheet as of December 31, 2020, the Company presented derivative liabilities of $2,161,000 as a long term liability. In presenting the Company’s consolidated balance sheet as of June 30, 2021, the Company has reclassified the derivative liabilities amount to a current liability. This reclassification has no effect on the Company’s results of operations, stockholders’ deficit, and cash flows previously reported.

Recently Issued Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company does not believe the potential impact of the new guidance and related codification improvements will be material to its financial position, results of operations and cash flows.

In August 2020, the FASB issued ASU No. 2020-06 (“ASU 2020-06”) “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40).” ASU 2020-06 reduces the number of accounting models for convertible debt instruments by eliminating the cash conversion and beneficial conversion models. As a result, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost as long as no other features require bifurcation and recognition as derivatives. By removing those separation models, the effective interest rate of convertible debt instruments will be closer to the coupon interest rate. Further, the diluted net income per share calculation for convertible instruments will require the Company to use the if-converted method. For contracts in an entity’s own equity, the type of contracts primarily affected by this update are freestanding and embedded features that are accounted for as derivatives under the current guidance due to a failure to meet the settlement conditions of the derivative scope exception. This update simplifies the related settlement assessment by removing the requirements to (i) consider whether the contract would be settled in registered shares, (ii) consider whether collateral is required to be posted, and (iii) assess shareholder rights. ASU 2020-06 will be effective January 1, 2024, for the Company and the provisions of this update can be adopted using either the modified retrospective method or a fully retrospective method. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. Effective January 1, 2021, the Company early adopted ASU 2020-06 and that adoption did not have an impact on our financial statements and the related disclosures.

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. ASU 2021-04 provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. An issuer measures the effect of a modification or exchange as the difference between the fair value of the modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange. ASU 2021-04 introduces a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and modifications unrelated to equity issuance and debt origination or modification). ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. Early adoption is permitted for all entities, including adoption in an interim period. If an entity elects to early adopt ASU 2021-04 in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The adoption of ASU 2021-04 is not expected to have a material impact on the Company’s financial statements or disclosures.

Other recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

NOTE 2 -– ~~PROPERTY~~CONTRACT ~~AND~~OBLIGATION ~~EQUIPMENT~~ACQUIRED FROM RELATED PARTIES

~~Property~~In ~~and~~May ~~equipment~~2018, ~~consist~~the Company entered into an acquisition agreement with the members, which in the aggregate, owned 100% of the ~~following~~membership atinterests in ~~March~~YLK, a related party. The major asset of YLK is a Cultivation Management Services Agreement (the “Management Agreement”) with an Arizona licensee that was entered into on January 5, 2018. During the year ended December 31, ~~2021~~2019, the Company determined the acquired assets were fully impaired, and recorded an impairment charge of $1,139,000 accordingly. The Company has a continuing obligation under the Management Agreement of $816,000 (net of discount of $34,000) as of December 31, 2020:. As of June 30, 2021, the remaining Management Agreement obligation was $824,000 (net of discount of $26,000) and is reflected as a current liability in the accompanying consolidated balance sheet. As of June 30, 2021, the Company is past due on its installment payments obligations under the Management Agreement.

	March 31, 2021			December 31, 2020
Machinery and equipment	$	81,000		$	67,000
Computer equipment		11,000			11,000
Furniture and fixtures		48,000			40,000
Leasehold improvements		10,000			-
		150,000			118,000
Less: accumulated depreciation		(106,000	)		(103,000	)
Property and equipment, net	$	44,000		$	15,000

Depreciation expense for the three months ended March 31, 2021 and 2020 was $3,000 and $2,000, respectively.

NOTE 3 – CONTRACT OBLIGATION ACQUIRED FROM RELATED PARTIES

In May 2018, the Company entered into an acquisition agreement with the members, which in the aggregate, owned 100% of the membership interests in YLK, a related party. The major asset of YLK is a Cultivation Management Services Agreement (the “Management Agreement”) with an Arizona licensee that was entered into on January 5, 2018. During the year ended December 31, 2019, the Company determined the acquired assets were fully impaired, and recorded an impairment charge of $1,139,000 accordingly. The Company has a continuing obligation under the Management Agreement of $816,000 (net of discount of $34,000) as of December 31, 2020. As of March 31, 2021, the remaining Management Agreement obligation was $820,000 (net of discount of $30,000) and is reflected as a current liability in the accompanying consolidated balance sheet. As of March 31, 2021, the Company is past due on its installment payments obligations under the Management Agreement.

NOTE 4 – NOTES PAYABLE TO RELATED PARTIES – PAST DUE

Notes payable to related parties consists of the following at March 31, 2021 and December 31, 2020:

	March 31, 2020		December 31, 2020
Notes payable to officers/shareholders – past due (a)		600,000		600,000
Notes payable to related party – past due (b)		150,000		150,000
Notes payable to related parties – past due (c)		40,000		40,000
Total	$	790,000	$	790,000

a.NOTE 3 On– ~~May~~NOTES 9,PAYABLE ~~2016,~~TO ~~the~~RELATED ~~Company~~PARTIES ~~entered~~– ~~into~~PAST note payable agreements with Alan Lien and Alvin Hao, each a former officer and director, to borrow $300,000 under each individual note. Pursuant to the terms of each of these agreements, the Company borrowed $300,000 from each of Alan Lien and Alvin Hao. The notes accrue interest at a rate of 8% per annum, are unsecured and were due on or before May 31, 2018. The loans are currently past due. A total of $600,000 was due on the combined notes at March 31, 2021 and December 31, 2020. b. On May 8, 2019, the Company entered into a note agreement with the sister of Alvin Hao, a former officer and director, to borrow $150,000. The loan accrues interest at 8% per annum (12% on default), is unsecured and is due on November 8, 2019. The note is currently past due. A total of $150,000 was due on the loans as of March 31, 2021 and December 31, 2020. c. The Company entered into note agreements with the parents of Alan Lien, the Company’s Chief Executive Officer and one of its directors. The loans accrue interest at 10% per annum, are unsecured and were due on or before December 31, 2016. The loans are currently past due. A total of $40,000 was due on the loans as of March 31, 2021 and December 31, 2020.DUE

AtNotes ~~December 31, 2020, accrued interest on the notes~~ payable to related parties ~~was~~consists ~~$187,000.~~of ~~During~~ the ~~three~~following ~~months~~at ~~ended~~June ~~March 31~~30, 2021~~, the~~ ~~Company added $17,000 of additional accrued interest,~~ and ~~made~~December ~~interest payments of $7,000, leaving an accrued interest on the notes payable to related parties balance of $197,000 at March~~ 31, ~~2021.~~2020:

~~NOTE~~ SCHEDULE 5OF –NOTES ~~LEASE~~ PAYABLE TO RELATED PARTIES

	June 30, 2021		December 31, 2020

Notes payable to officers/shareholders – past due (a)	$	600,000	$	600,000
Notes payable to related party – past due (b)		150,000		150,000
Notes payable to related parties – past due (c)		40,000		40,000
Total	$	790,000	$	790,000

	a.	On May 9, 2016, the Company entered into note payable agreements with Alan Lien and Alvin Hao, each a former officer and director of the Company, to borrow $300,000 each under individual notes. Pursuant to the terms of each of these agreements, the Company borrowed $300,000 each from Alan Lien and Alvin Hao. The notes accrue interest at a rate of 8% per annum, are unsecured and were due May 31, 2018. The loans are currently past due. A total of $600,000 was due on the combined notes at June 30, 2021 and December 31, 2020.

	b.	On May 8, 2019, the Company entered into a note agreement with the sister of Alvin Hao, a former officer and director of the Company, to borrow $150,000. The loan accrues interest at 8% per annum (12% on default), is unsecured and was due on November 8, 2019. The note is currently past due. A total of $150,000 was due on the loans as of June 30, 2021 and December 31, 2020.

	c.	The Company entered into note agreements with the parents of Alan Lien, a former officer and director of the Company. The loans accrue interest at 10% per annum, are unsecured and were due December 31, 2016. The loans are currently past due. A total of $40,000 was due on the loans as of June 30, 2021 and December 31, 2020.

At December 31, 2020, accrued interest on the notes payable to related parties was $187,000. During the six months ended June 30, 2021, the Company added $35,000 of additional accrued interest, and made interest payments of $15,000, leaving an accrued interest on the notes payable to related parties balance of $207,000 at June 30, 2021.

NOTE 4 – LEASE LIABILITEIS

The Company leases its executive offices and warehouse space. The Company analyzes all leases at inception to determine if a right-of-use (“ROU”) asset and lease liability should be recognized. Leases with an initial term of 12 months or less are not included on the condensed consolidated balance sheets. The ROU asset and lease liability is measured at the present value of future lease payments as of the lease commencement date. The Company accounts for the lease and non-lease components of its leases as a single lease component. Rent expense is recognized on a straight-line basis over the lease term.

In 2019, we occupied a 17,640 square foot facility located at 853 Sandhill Avenue, Carson, California under a five-year lease with an independent party ending on June 30, 2023, pursuant to which we paid $15,000 per month in rental charges. On December 31, 2019, we abandoned our Carson, California lease. The Company remains obligated under its Carson, California lease, until such time the landlord releases us from our lease agreement. During the ~~three-~~six months ended ~~March~~June 3130, 2020, management determined it no longer had access to the Carson, California facility, and recorded an impairment charge for the remaining ROU asset balance of $82,000. As of the date of this report, the Company has not been released from the lease agreement, and no lease payments were made during the ~~three~~six months ended ~~March~~June 3130, 2021. The remaining balance of the lease ~~obligation~~ liability was $556,000 at both ~~March~~June 3130, 2021 and December 31, 2020.

On January 1, 2020, the Company relocated its principal executive offices and warehouse to 1689-A Arrow Rt., Upland, California, 91786. The Upland, California lease is for a 2,974 square foot facility under a three-year lease with an independent party ending on January 31, 2023, pursuant to which the Company pays $2,800 per month in rental charges. The operating lease ROU asset balance related to the Upland, California operating lease was $63,000 as of December 31, 2020. During the ~~three~~six months ended ~~March~~June 3130, 2021, the Company reflected amortization of the ROU assets of $714,000 related to its Upland, California operating lease, resulting in an ROU asset balance of $5649,000 as of ~~March~~June 3130, 2021.

On January 11, 2021, the Company opened a regional sales and distribution office at Windolph Plaza Center, 1020 NW 6th Street, Bay G, Deerfield Beach in Broward County, Florida. The Florida lease is for a 4,304 square foot facility under a five-year and two-month lease with an independent party ending on March 31, 2026, pursuant to which it pays an average $3,691 per month in rental charges. On January 11, 2021, the Company recognized an operating lease ROU asset and lease liability of $173,000, related to the Florida operating lease. During the three months ended March 31, 2021, the Company reflected amortization of the ROU assets of $4,000 related to its Florida operating lease, resulting in an ROU asset balance of $169,000 as of March 31, 2021.

As of December 31, 2020, liabilities recorded under operating leases were $622,000. During the three months ended March 31, 2021, the Company added $173,000 in lease liabilities related to its Florida operating lease, and made lease payments of $4,000 towards its operating lease liability. As of March 31, 2021, liabilities under operating leases amounted to $791,000, of which $380,000 were reflected as current due.

On January 11, 2021, the Company opened a regional sales and distribution office at Windolph Plaza Center, 1020 NW 6th Street, Bay G, Deerfield Beach in Broward County, Florida. The Florida lease ~~agreements~~is ~~above~~for ~~have~~a 4,304 square foot facility under a ~~weighted~~five-year ~~average remaining~~and two-month lease ~~term~~with ofan ~~2.85~~independent ~~years~~party asending ofon March 31, ~~2021~~2026, ~~and~~pursuant ~~the~~to ~~weighted~~which it pays an average ~~discount~~$3,691 ~~rate~~per ~~for~~month in rental charges. On January 11, 2021, the Company recognized an operating ~~leases~~lease isROU ~~10%.~~asset ~~Rent~~and ~~expense~~lease liability of $173,000, related to the Florida operating ~~during~~lease. During the ~~three~~six months ended ~~March~~June 3130, 2021, ~~and~~the ~~2020~~Company ~~was~~reflected amortization of the ROU assets of $1810,000 ~~and~~related to its Florida operating lease, resulting in an ROU asset balance of $6163,000 as of June 30, ~~respectively~~2021.

As of December 31, 2020, liabilities recorded under operating leases were $622,000. During the six months ended June 30, 2021, the Company added $173,000 in lease liabilities related to its Florida operating lease, and made lease payments of $16,000 towards its operating lease liability. As of June 30, 2021, liabilities under operating leases amounted to $779,000, of which $424,000 were reflected as current due.

The lease agreements above have a weighted average remaining lease term of 2.58 years as of June 30, 2021, and the weighted average discount rate for operating leases is 10%. Rent expense during the three and six months ended June 30, 2021 and 2020 was $28,000 and $6,000, and $47,000 and $63,000, respectively.

Maturities of the Company’s lease liabilities are as follows:

Year Ending	Operating Leases
Remainder of 2021	$	446,000
2022		265,000
2023		142,000
2024		49,000
2025		44,000
Thereafter		11,000
Total lease payments		957,000
Less: Imputed interest		(166,000	)
Total operating lease liability		791,000
Current portion		(380,000	)
	$	411,000

NOTE 6 – LEGAL OBLIGATION PAYABLE

Year Ending	Operating Leases
Remainder of 2021	$	414,000
2022		265,000
2023		142,000
2024		49,000
2025		53,000
Thereafter		14,000
Total lease payments		937,000
Less: Imputed interest		(158,000	)
Total operating lease liabilities		779,000
Lease liabilities, current portion		(424,000	)
Lease liabilities, net of current portion	$	355,000

~~Effective~~NOTE ~~June~~5 ~~25,~~– ~~2018,~~LEGAL ~~Matthew~~SETTLEMENT Geschke (the “Plaintiff”) filed a breach of contract case against the Company in the San Diego Superior Court of San Diego, California. The Plaintiff claimed damages for breach of an employment contract when the Company terminated the Plaintiff’s employment agreement on February 22, 2018. On June 26, 2020, the Plaintiff was awarded a default judgment against the Company in the amount of $448,000. No payments have been made, leaving $448,000 owed at March 31, 2021 and December 31, 2020.PAYABLE

~~NOTE~~Effective 7June –25, ~~LOANS~~2018, ~~PAYABLE~~Matthew Geschke (the “Plaintiff”) filed a breach of contract case against the Company in the San Diego Superior Court of San Diego, California. The Plaintiff claimed damages for breach of an employment contract when the Company terminated the Plaintiff’s employment agreement on February 22, 2018. On June 26, 2020, the Plaintiff was awarded a default judgment against the Company in the amount of $448,000. No payments have been made, and $448,000 is payable at June 30, 2021 and December 31, 2020.

~~Notes~~NOTE ~~payable~~6 ~~consists~~– ofLOANS ~~the following at March 31, 2021 and December 31, 2020:~~PAYABLE

	March 31, 2021		December 31, 2020
Notes payable to Celtic Bank – past due (a)	$	-	$	11,000
SBA Paycheck Protection Program loan (b)		205,000		205,000
SBA Economic Injury Disaster Loan (c)		150,000		150,000
Total loans payable		355,000		366,000
Loans payable, current portion		-		(11,000	)
Loans payable, net of current portion	$	355,000	$	355,000

Notes payable consists of the following at June 30, 2021 and December 31, 2020:

	a)	On May 21, 2019, the Company entered into a loan agreement with Celtic Bank in the principal amount of $150,000 with interest at 40.44% per annum and due on May 21, 2020. The loan was guaranteed by Alvin Hao, a former officer of the Company. A total of $11,000 was owed on the loan as of December 31, 2020. During the three months ended March 31, 2021, the Company entered into a settlement agreement with Celtic Bank, whereas the Company agreed to make a reduced payment in full of $9,000, and recorded a gain on extinguishment of debt of $2,000, as reflected in the condensed consolidated statements of income during the three months ended March 31, 2021.
	b)	On May 7, 2020, the Company was granted a loan (the “PPP loan”) from Wells Fargo Bank in the aggregate amount of $205,000, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act.
		The PPP loan agreement is dated May 8, 2020, matures on May 7, 2022, bears interest at a rate of 1% per annum, with the first six months of interest deferred, and is unsecured and guaranteed by the U.S. Small Business Administration (“SBA”). The loan term may be extended to May 7, 2025, if mutually agreed to by the Company and lender. The Company applied ASC 470, Debt, to account for the PPP loan. The PPP loan may be prepaid at any time prior to maturity with no prepayment penalties. Funds from the PPP loan may only be used for qualifying expenses as described in the CARES Act, including qualifying payroll costs, qualifying group health care benefits, qualifying rent and debt obligations, and qualifying utilities. The Company intends to use the entire loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses. The Company intends to apply for forgiveness of the PPP loan with respect to these qualifying expenses, however, it cannot assure that such forgiveness of any portion of the PPP loan will occur. As for the potential loan forgiveness, once the PPP loan is, in part or wholly, forgiven and a legal release is received, the liability would be reduced by the amount forgiven and a gain on extinguishment would be recorded. The terms of the PPP loan provide for customary events of default including, among other things, payment defaults, breach of representations and warranties, and insolvency events. The Company was in compliance with the terms of the PPP loan as of March 31, 2021. A total of $205,000 was due on the PPP loan as of March 31, 2021 and December 31, 2020.

SCHEDULE OF LOANS PAYABLE

	June 30, 2021		December 31, 2020

Notes payable to Celtic Bank – past due (a)	$	-	$	11,000
SBA Paycheck Protection Program loan (b)		205,000		205,000
SBA Economic Injury Disaster Loan (c)		150,000		150,000
Total loans payable		355,000		366,000
Loans payable, current portion		-		(11,000	)
Loans payable, net of current portion	$	355,000	$	355,000

c) On June 7, 2020, the Company obtained an Economic Injury Disaster Loan (“EIDL”) from the SBA in the amount of $150,000. Interest on the loan is at the rate of 3.75% per year, and all loan payments are deferred for twenty four months, at which time the balance is payable in monthly installments of $731 over a 30-year term. The loan is secured by all the Company’s assets. The Company was in compliance with the terms of the EIDL as of March 31, 2021. A total of $150,000 was due on the EIDL loan as of March 31, 2021 and December 31, 2020.

	a)	On May 21, 2019, the Company entered into a loan agreement with Celtic Bank in the principal amount of $150,000 with interest at 40.44% per annum and due on May 21, 2020. The loan was guaranteed by Alvin Hao, a former officer of the Company. A total of $11,000 was owed on the loan as of December 31, 2020. During the six months ended June 30, 2021, the Company entered into a settlement agreement with Celtic Bank, whereas the Company agreed to make a reduced payment in full of $9,000, and recorded a gain on extinguishment of debt of $2,000, as reflected in the condensed consolidated statements of income during the six months ended June 30, 2021.

	b)	On May 7, 2020, the Company was granted a loan (the “PPP loan”) from Wells Fargo Bank in the aggregate amount of $205,000, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act.

		The PPP loan agreement is dated May 8, 2020, matures on May 7, 2022, bears interest at a rate of 1% per annum, with the first six months of interest deferred, and is unsecured and guaranteed by the U.S. Small Business Administration (“SBA”). The loan term may be extended to May 7, 2025, if mutually agreed to by the Company and lender. The Company applied ASC 470, Debt, to account for the PPP loan. The PPP loan may be prepaid at any time prior to maturity with no prepayment penalties. Funds from the PPP loan may only be used for qualifying expenses as described in the CARES Act, including qualifying payroll costs, qualifying group health care benefits, qualifying rent and debt obligations, and qualifying utilities. The Company intends to use the entire loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses. The Company intends to apply for forgiveness of the PPP loan with respect to these qualifying expenses, however, it cannot assure that such forgiveness of any portion of the PPP loan will occur. As for the potential loan forgiveness, once the PPP loan is, in part or wholly, forgiven and a legal release is received, the liability would be reduced by the amount forgiven and a gain on extinguishment would be recorded. The terms of the PPP loan provide for customary events of default including, among other things, payment defaults, breach of representations and warranties, and insolvency events. The Company was in compliance with the terms of the PPP loan as of June 30, 2021. A total of $205,000 was due on the PPP loan as of June 30, 2021 and December 31, 2020.

~~NOTE 8~~c) –On ~~CONVERTIBLE~~June ~~SECURED~~7, ~~NOTE~~2020, ~~PAYABLE~~the TOCompany ~~RELATED~~obtained ~~PARTY~~an Economic Injury Disaster Loan (“EIDL”) from the SBA in the amount of $150,000. Interest on the loan is at the rate of 3.75% per year, and all loan payments are deferred for twenty four months, at which time the balance is payable in monthly installments of $731 over a 30-year term. The loan is secured by all the Company’s assets. The Company was in compliance with the terms of the EIDL as of June 30, 2021. A total of $150,000 was due on the EIDL loan as of June 30, 2021 and December 31, 2020.

~~Secured~~NOTE ~~notes~~7 ~~payable~~– toCONVERTIBLE ~~related~~SECURED ~~party~~NOTE ~~consists~~PAYABLE ofTO ~~the~~RELATED ~~following as of March 31, 2021 and December 31, 2020:~~PARTY

	March 31, 2021			December 31, 2020
YA II PN, Ltd.	$	2,275,000		$	2,275,000
Less debt discount		(37,000	)		(220,000	)
Secured note payable, net	$	2,238,000		$	2,055,000

Secured notes payable to related party consists of the following as of June 30, 2021 and December 31, 2020:

On SCHEDULE ~~May~~OF ~~10,~~SECURED ~~2018~~NOTE ~~and~~PAYABLE ~~October~~TO ~~29,~~RELATED 2019, the Company issued convertible secured debentures (“Notes”) to YA II PN Ltd. (“YA II PN”) in the principal amounts of $1,500,000 and $275,000, respectively, with interest rates of 8% and 10%, respectively, which matured in June 2020 and April 2020, respectively. The notes are currently past due. The Company is in discussion with YA II PN to extend the maturity date of the Notes. The Notes provide a conversion right, in which the principal amount of the Note, together with any accrued but unpaid interest, could be converted into the Company’s common stock at a conversion price at 75% of the lowest volume weighted average price (VWAP) of the Company’s Common Stock during the 10 trading days immediately preceding the conversion date. PARTY

In 2019, the Company entered into an amendment agreements with YA II, PN, which amended the secured promissory note in the principal face amount of $1.5 million issued on May 10, 2018. The Company calculated the fair market value of the secured note payable before and after the modifications and recorded the difference of $962,000 as a debt extinguishment cost in 2019.

	June 30, 2021			December 31, 2020

YA II PN, Ltd.	$	2,275,000		$	2,275,000
Less debt discount		(12,000	)		(220,000	)
Secured note payable, net	$	2,263,000		$	2,055,000

AsOn ~~part~~May of10, ~~the~~2018 ~~issuance~~and ofOctober ~~the~~29, ~~Notes~~2019, the Company ~~also~~issued ~~granted~~convertible secured debentures (“Notes”) to YA II PN ~~5-year~~Ltd. ~~warrants,~~(“YA II ~~which~~PN”) ~~were~~in ~~modified,~~the toprincipal ~~purchase~~amounts ~~a total~~ of 13$1,~~000~~500,000 ~~shares~~ ofand ~~the~~$275,000, ~~Company~~respectively, atwith aninterest ~~exercise~~rates ~~price~~ of ~~$0.05~~8% ~~per~~and ~~share~~10%, ~~with~~as ~~expiration~~amended, ~~dates~~respectively, which ~~ranging~~matured ~~from~~in ~~May~~June ~~2024~~2020 toand ~~December~~April ~~2024. 7~~2020,~~500,000 warrants~~ ~~granted~~respectively. asThe ~~part~~notes ofare ~~the~~currently ~~Note~~past ~~issuances~~due. ~~were~~The ~~also~~Company ~~modified~~is toin ~~ultimately~~discussion ~~change~~with ~~the~~YA ~~exercise~~II ~~price~~PN to ~~from~~extend ~~$0.50~~the ~~per~~maturity ~~share~~date ~~(1,000,000 warrants),~~of $0the Notes.75 ~~per~~The ~~share~~Notes ~~(2,250,000~~provide ~~warrants),~~a ~~$1.00~~conversion ~~per~~right, ~~share~~in ~~(2,250,000~~which ~~warrants)~~the ~~and~~principal ~~$1.25~~amount ~~per~~of ~~share~~the (2Note,~~000,000~~ ~~warrants)~~together ~~to $0.05~~with ~~per~~any ~~share~~accrued ~~for~~but ~~all~~unpaid ~~four warrants. Furthermore~~interest, ~~the~~could ~~amendments~~be ~~removed~~converted into the Company’s ~~right~~common ofstock ~~redemption~~at ~~and~~a ~~right~~conversion toprice ~~compel~~at ~~exercise on~~75% ~~certain~~of ~~Warrants.~~the ~~The~~lowest volume ~~Company~~weighted ~~calculated~~average ~~the~~price ~~fair~~(VWAP) ~~market value~~ of the ~~warrants~~Company’s ~~before~~Common ~~and~~Stock ~~after~~during the ~~modifications~~10 ~~above~~trading ~~and recorded~~days ~~the~~immediately ~~difference~~preceding ofthe ~~$194,000 as a financing cost in 2019~~conversion date.

As part of the issuance of the Notes, the Company also granted YA II PN 5-year warrants, which were modified, to purchase a total of 13,000,000 shares of the Company at an exercise price of $0.05 per share, with expiration dates ranging from May 2024 to December 2024. 7,500,000 warrants granted as part of the Note issuances were also modified to ultimately change the exercise price from $0.50 per share (1,000,000 warrants), $0.75 per share (2,250,000 warrants), $1.00 per share (2,250,000 warrants) and $1.25 per share (2,000,000 warrants) to $0.05 per share for all four warrants. Furthermore, the amendments removed the Company’s right of redemption and right to compel exercise on certain Warrants. The Company calculated the fair market value of the warrants before and after the modifications above and recorded the difference of $194,000 as a financing cost in 2019.

On February 13, 2020, the Company issued a note (the “2020 Note”) to YAII PN in the amount of $150,000. The 2020 Note bears interest at a rate of 10% per annum (15% on default) and has a maturity date of August 10, 2021. The Company received net proceeds of $125,000, net of closing costs of $25,000. The 2020 Note is secured by all the assets of the Company and its subsidiaries. The 2020 Note provides a conversion right, in which any portion of the principal amount of the 2020 Note, together with any accrued but unpaid interest, may be converted into the Company’s common stock at a conversion price equal to 75% of the lowest VWAP of the Company’s common stock during the ten (10) trading days immediately preceding the date of conversion, subject to adjustment. As such, the Company determined that the conversion feature created a derivative with a fair value of $109,000 at the date of issuance. The Company also granted YA II PN 5-year warrants with a fair value of $66,000, to purchase a total of 3,000,000 shares of the Company at an exercise price of $0.05 per common share. The aggregate amount of the closing costs, and the fair value of the derivative liability, was $177,000, of which $150,000 was recorded as a valuation discount on the 2020 Note to be amortized over the life of the 2020 Note, and $27,000 was recorded as a financing cost.

On September 23, 2020, the Company issued a note (the “September 2020 Note”) to YAII PN in the amount of $350,000. The September 2020 Note bears interest at a rate of 10% per annum (15% on default) and has a maturity date of March 23, 2021. The Company received net proceeds of $340,000, net of closing costs of $10,000. The September 2020 Note is secured by all the assets of the Company and its subsidiaries. The September 2020 Note provides a conversion right, in which any portion of the principal amount of the September 2020 Note, together with any accrued but unpaid interest, may be converted into the Company’s common stock at a conversion price equal to 75% of the lowest VWAP of the Company’s common stock during the ten (10) trading days immediately preceding the date of conversion, subject to adjustment. As such, the Company determined that the conversion feature created a derivative with a fair value of $322,000 at the date of issuance. The Company also granted YA II PN 5-year warrants with a fair value of $68,000, to purchase a total of 7,000,000 shares of the Company at an exercise price of $0.05 per common share. The aggregate amount of the closing costs, and the fair value of the warrants and derivative liability, was $389,000, of which $350,000 was recorded as a valuation discount on the September 2020 Note to be amortized over the life of the September 2020 Note, and $39,000 was recorded as a financing cost.

The remaining unamortized balance of the valuation discount was $220,000 at December 31, 2020. During the ~~three~~six months ended ~~March~~June 3130, 2021, amortization of valuation discount was $~~183~~208,000 and was recorded as an interest cost, leaving a $3712,000 remaining unamortized balance of the valuation discount at ~~March~~June 3130, 2021.

At December 31, 2020, accrued interest on the convertible secured notes payable to related parties of $344,000 was included in accrued interest to related parties on the consolidated balance sheet. During the ~~three~~six months ended ~~March~~June 3130, 2021, the Company added $4998,000 of additional accrued interest, leaving an accrued interest to related parties balance of $~~393~~442,000 at ~~March~~June 3130, 2021.

As of ~~March~~June 3130, 2021, 70101,~~033~~732,~~933~~281 shares of common stock were potentially issuable under the conversion terms of the convertible secured notes.

NOTE 98 – DERIVATIVE LIABILITY

The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The conversion prices and the exercise prices of the warrants described in Note 8 were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.

As of ~~March~~June 3130, 2021 and December 31, 2020, the derivative liabilities were valued using a Black-Scholes Merton pricing model with the following assumptions:

	March 31, 2021			Issued During 2021			December 31, 2020
Exercise Price	$	0.033		$	-		$	0.05
Stock Price	$	0.048		$	-		$	0.013
Risk-free interest rate		0.07	%		-	%		0.09	%
Expected volatility		299	%		-	%		268-278	%
Expected life (in years)		1.0			-			0.25-0.62
Expected dividend yield		0	%		-	%		0	%
Fair Value: Conversion Feature	$	3,598,000		$	-		$	2,161,000

	June 30, 2021			Issued During 2021			December 31, 2020

Exercise Price	$	0.024		$	-		$	0.05
Stock Price	$	0.028		$	-		$	0.013
Risk-free interest rate		0.07	%		-	%		0.09	%
Expected volatility		261	%		-	%		268-278	%
Expected life (in years)		1.0			-			0.25-0.62
Expected dividend yield		0	%		-	%		0	%

Fair Value: Conversion Feature	$	2,886,000		$	-		$	2,161,000

The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future.

The following table sets forth a summary of the changes in the estimated fair value of our embedded derivative during the ~~three~~six months ended ~~March~~June 3130, 2021 and 2020:

	Three Months Ended
	March 31, 2021		March 31, 2020
Fair value at beginning of period	$	2,161,000	$	1,332,000
Recognition of derivative liabilities upon initial valuation		-		140,000
Extinguishment of derivative liabilities		-		-
Net change in the fair value of derivative liabilities		1,437,000		942,000
Fair value at end of period	$	3,598,000	$	2,414,000

NOTE 10 – SHAREHOLDERS’ EQUITY

	Six Months Ended
	June 30, 2021		June 30, 2020
Fair value at beginning of period	$	2,161,000	$	1,332,000
Recognition of derivative liabilities upon initial valuation		-		140,000
Extinguishment of derivative liabilities		-		-
Net change in the fair value of derivative liabilities		725,000		1,525,000
Fair value at end of period	$	2,886,000	$	2,997,000

NOTE 9 – SHAREHOLDERS’ EQUITY

Common Shares Issued to Directors

The Company appointed certain directors and issued shares as part of their director compensation agreements. During the ~~three~~six months ended ~~March~~June 3130, 2021, the Company issued an aggregate of ~~472~~1,~~000~~052,423 shares of common stock, with a fair value of $2040,000 at date of grant. During the ~~three~~six months ended ~~March~~June 3130, 2020, the Company issued an aggregate of 2,~~166~~631,~~667~~290 shares of common stock, with a fair value of $2352,000 at date of grant. The issued shares were recognized as compensation cost.

Common Shares Issued on Conversion of Convertible Note Payable

During the ~~three~~six months ended ~~March~~June 3130, 2020, the Company was notified by YA II PN (~~see~~See Note 87) in writing of their election to convert $29,000 of interest accrued into 2,287,066 shares of the Company’s common at $0.0127 per share.

Summary of Stock Options

A summary of stock options for the ~~three~~six months ended ~~March~~June 3130, 2021, is as follows:

			Weighted
	Number		Average
	of		Exercise
	Options		Price
Balance outstanding, December 31, 2020		10,002,210		0.077
Options granted		260,417		0.048
Options exercised		-		-
Options expired or forfeited		-		-
Balance outstanding, March 31, 2021		10,262,627	$	0.76
Balance exercisable, March 31, 2021		10,262,627	$	0.76

SUMMARY OF STOCK OPTIONS ACTIVITY

			Weighted Average
	Number of		Exercise
	Options		Price
Balance outstanding, December 31, 2020		10,002,210		0.077
Options granted		706,846		0.035
Options exercised		-		-
Options expired or forfeited		-		-
Balance outstanding, June 30, 2021		10,709,056	$	0.074
Balance exercisable, June 30, 2021		10,709,056	$	0.074

On January 1, 2021, the Company entered into a new five-year employment agreement with Tiffany Davis as the Company’s Chief Executive Officer. Ms. Davis is entitled to receive stock options of $12,500 of shares per quarter at the then closing market price on the last trading day at the end of each calendar quarter, which expire five years from the date of issuance. Accordingly, during the ~~three~~six months ended ~~March~~June 3130, 2021, Davis was granted a total of ~~260~~706,~~417~~846 stock options, with the fair value determined to be $1225,000, and was recorded to stock-based compensation expense during the ~~three~~six months ended ~~March~~June 3130, 2021. The fair value of options on the date of grant was ~~estimated~~ estimated using the Black-Scholes option pricing model with the following weighted average assumptions: stock price of $0.~~048~~035, risk-free ~~interest~~ interest rate of 0.3542%, expected volatility of ~~248~~251%, and an expected life of 3.0 years.

Information relating to outstanding options at ~~March~~June 3130, 2021, summarized by exercise price, is as follows:

		Outstanding						Exercisable
Exercise Price Per Share		Shares		Life (Years)		Weighted Average Exercise Price		Shares		Weighted Average Exercise Price
$	0.01-0.05		9,162,627		4.29	$	0.015		9,162,627	$	0.015
$	0.46		100,000		2.70	$	0.46		100,000	$	0.46
$	0.60		1,000,000		1.86	$	0.60		1,000,000	$	0.60
			10,262,627		2.34	$	0.077		10,262,627	$	0.077

As of December 31, 2020, the Company has no outstanding unvested options with future compensation costs. In addition, there will be future compensation related to the options to be awarded to Ms. Davis under her employment agreement discussed above. The weighted-average remaining contractual life of options outstanding and exercisable at March 31, 2021 was 2.34 years. Both the outstanding and exercisable stock options had an intrinsic value of $302,000 at March 31, 2021.

		Outstanding						Exercisable
Exercise Price Per Share		Shares		Life (Years)		Weighted Average Exercise Price		Shares		Weighted Average Exercise Price
	$ 0.01-0.05		9,609,056		5.65	$	0.017		9,609,056	$	0.017
$	0.46		100,000		2.45	$	0.46		100,000	$	0.46
$	0.60		1,000,000		1.61	$	0.60		1,000,000	$	0.60
			10,709,056		2.13	$	0.074		10,709,056	$	0.074

As of June 30, 2021, the Company has no outstanding unvested options with future compensation costs. In addition, there will be future compensation related to the options to be awarded to Ms. Davis under her employment agreement discussed above. The weighted-average remaining contractual life of options outstanding and exercisable at June 30, 2021 was 2.13 years. Both the outstanding and exercisable stock options had an intrinsic value of $126,000 at June 30, 2021.

Summary of Warrants

A summary of warrants for the ~~year~~six months ended ~~March~~June 3130, 2021, is as follows:

			Weighted
	Number		Average
	of		Exercise
	Warrants		Price
Balance outstanding, December 31, 2020		28,283,140		0.05
Warrants granted		4,000,000		0.001
Warrants exercised		-		-
Warrants expired or forfeited		-		-
Balance outstanding, March 31, 2021		32,283,140	$	0.05
Balance exercisable, March 31, 2021		32,283,140	$	0.05

SCHEDULE OF STOCK WARRANTS ACTIVITY

Information relating to outstanding warrants at March 31, 2021, summarized by exercise price, is as follows:

			Weighted Average
	Number of		Exercise
	Warrants		Price
Balance outstanding, December 31, 2020		28,283,140		0.05
Warrants granted		4,000,000		0.001
Warrants exercised		-		-
Warrants expired or forfeited		-		-
Balance outstanding, June 30, 2021		32,283,140	$	0.05
Balance exercisable, June 30, 2021		32,283,140	$	0.05

		Outstanding						Exercisable
Exercise Price Per Share		Shares		Life (Years)		Weighted Average Exercise Price		Shares		Weighted Average Exercise Price
$	0.001		4,000,000		5.00	$	0.01		4,000,000	$	0.01
$	0.01		5,000,000		2.11	$	0.01		5,000,000	$	0.01
$	0.05		23,000,000		3.41	$	0.05		23,000,000	$	0.05
$	1.10		283,140		1.56	$	1.10		283,140	$	1.10
			32,283,140		3.39	$	0.05		32,283,140	$	0.05

~~During~~Information ~~the~~relating ~~three~~to ~~months~~outstanding ~~ended March 31, 2021, the Company issued five-year~~ warrants ~~with~~at aJune ~~fair value of $191~~30,~~000~~ ~~to purchase 4~~2021,~~000,000~~ ~~shares of~~summarized ~~common~~by ~~stock at an~~ exercise price, ofis ~~$0.001~~ as part of a settlement agreement regarding a trade vendor payable (see Note 11). The fair value of warrants on the date of grant was estimated using the Black-Scholes option pricing model with the following weighted average assumptionsfollows: ~~stock price of $0.048, risk-free interest rate of 0.35%, expected volatility of 248%, and an expected life of 3.0 years.~~

~~The~~ SCHEDULE ~~weighted-average~~OF ~~remaining~~WARRANTS ~~contractual~~OUTSTANDING ~~life~~AND ~~of warrants outstanding and exercisable at December 31, 2020 was 3.39 years. Both the outstanding and exercisable warrants had an intrinsic value of $378,000 at March 31, 2021.~~EXERCISABLE

NOTE 11 – COMMITMENTS AND CONTINGENCIES

		Outstanding						Exercisable
Exercise Price Per Share		Shares		Life (Years)		Weighted Average Exercise Price		Shares		Weighted Average Exercise Price
$	0.001		4,000,000		4.75	$	0.01		4,000,000	$	0.01
$	0.01		5,000,000		1.86	$	0.01		5,000,000	$	0.01
$	0.05		23,000,000		3.17	$	0.05		23,000,000	$	0.05
$	1.10		283,140		1.31	$	1.10		283,140	$	1.10
			32,283,140		3.14	$	0.05		32,283,140	$	0.05

During the six months ended June 30, 2021, the Company issued five-year warrants with a fair value of $191,000 to purchase 4,000,000 shares of common stock at an exercise price of $0.001 as part of a settlement agreement regarding a trade vendor payable (see Note 10). The fair value of warrants on the date of grant was estimated using the Black-Scholes option pricing model with the following weighted average assumptions: stock price of $0.048, risk-free interest rate of 0.35%, expected volatility of 248%, and an expected life of 3.0 years.

The weighted-average remaining contractual life of warrants outstanding and exercisable at December 31, 2020 was 3.14 years. Both the outstanding and exercisable warrants had an intrinsic value of $198,000 at June 30, 2021.

NOTE 10 – COMMITMENTS AND CONTINGENCIES

On March 30, 2021, the Company entered into a Settlement Agreement and Release (“Agreement”) with Sichenzia Ross Ference LLP (“SRF”), for services that were performed for the Company. The Company owed SRF $160,000, of which the Company agreed to pay SRF the sum total $75,000. The $75,000 is payable in fifteen monthly installments, commencing on March 31, 2021, and with the last installment payment due no later than May 31, 2022. As an alternative to the Settlement Payment, the Company shall have the option to pay to SRF:

a. An initial installment payment of $5,000 on or before March 31, 2021, $5,000 on or before April 30, 2021, and a lump sum payment of $40,000 on or before June 7, 2021, for a total payments of $50,000; or

b. An initial installment payment of $5,000 on or before March 31, 2021, $5,000 on or before April 30, 2021, $5,000 on or before May 31, 2021, $5,000 on or before June 30, 2021, $5,000 on or before July 30, 2021 and a lump sum payment of $50,000 on or before August 6, 2021 for a total payments of $75,000.

As further consideration of the full and final settlement of these matters, the Company issued to SRF, a cashless five-year warrant to purchase 4,000,000 shares of common stock of the Company at an exercise price per share equal to $0.001 per share and a fair value of $191,000 on the date granted.

The total settlement amount was $266,000, made up the $75,000 reduced payable to SFR, plus the fair value of the warrants of $191,000, which was more than the original trade vendor balance owed of $160,000. The difference of $106,000 was recorded as a component of loss on settlement of trade vendor payable on the accompanying condensed consolidated statements of operations for the ~~three~~six months ended ~~March~~June 3130, 2021.

Technology License Agreement

The Company entered into a Technology License Agreement with a third-party vendor for consulting services. Under the agreement, the Company will pay the vendor a minimum consulting amount of $100,000 per year, plus a royalty of 7% of all net sales of the vendor’s products above $1,429,000 per calendar year. For the three and six months ended ~~March~~June 3130, 2021 and 2020, $25,000 and $50,000, and $25,000 and $50,000 was recorded as research and development expense under the agreement on the ~~Condensed~~condensed ~~Consolidated~~consolidated ~~Statements~~statements of ~~Operations~~operations related to the minimum annual fee. For ~~the~~each ~~three~~of six months ended ~~March~~June 3130, 2021 and 2020, no royalty was recorded as cost of goods sold on the Condensed Consolidated Statements of Operations. A total of $~~364~~389,000 and $339,000 was owed under the amended agreement at ~~March~~June 3130, 2021 and December 30 31, 2020, respectively, and is included in accounts payable and accrued liabilities on the accompanying condensed consolidated balance sheets.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations includes a number of forward-looking statements that reflect Management’s current views with respect to future events and financial performance. You can identify these statements by forward-looking words such as “may,” “will,” “expect,” “anticipate,” “believe,” “estimate” and “continue,” or similar words. Those statements include statements regarding the intent, belief or current expectations of us and members of our management team as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.

Readers are urged to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the Securities and Exchange Commission. Important factors currently known to Management could cause actual results to differ materially from those in forward-looking statements. We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in the future operating results over time. We believe that our assumptions are based upon reasonable data derived from and known about our business and operations. No assurances are made that actual results of operations or the results of our future activities will not differ materially from our assumptions. Factors that could cause differences include, but are not limited to, expected market demand for our products, fluctuations in pricing for materials, and competition.

Business Overview

We are focused on the research, design, development and manufacturing of advanced, energy efficient indoor horticulture lighting, plant nutrient products, and ancillary equipment. Our vision is to apply the latest advances in high efficiency lighting and controls technology as well as effective manufacturing techniques to deliver highly differentiated lighting and nutrient products with clear benefits at competitive prices to the greenhouse and indoor horticulture markets.

Our subsidiary, Solis Tek, Inc., a California corporation, was formed in June of 2010. Its operations consist of designing, developing and sourcing of a line of Solis Tek Digital Ballasts intended for use in high intensity lighting systems used for horticulture. An electrical ballast is a device intended to limit the amount of current in an electric circuit. A familiar and widely used example is the inductive ballast used in fluorescent lamps, which limits the current through the tube, which would otherwise rise to destructive levels due to the tube’s negative resistance characteristic. Since the commencement of operations, our product line has evolved from digital ballasts to a line of lighting products including a line of specialty ballasts ranging from 400 watts to 1,000 watts with various features, our Lamp Products, a line of reflectors, high intensity lighting accessories and a new line of LED lighting technologies.

Results of Operations

Results of Operations for the three months ended ~~March~~June 3130, 2021 compared to the three months ended ~~March~~June 3130, 2020.

Revenue and Cost of Goods Sold

Revenue for the three months ended ~~March~~June 3130, 2021 and 2020 was $~~454~~463,000 and $~~307~~276,000, respectively, an increase of $~~147~~187,000, or 4868%. ~~Revenue for the three months ended March 31, 2021 and 2020 was $454,000 and $307,000, respectively, an increase of $147,000, or 48%.~~ The increase is due to two factors 1) the company’s initiative to focus direct sales and marketing efforts on its nutrient business and 2) the increase in new markets that are granting new cultivation licenses which resulted in new companies obtaining licenses to legally grow cannabis, which has ultimately resulted in new order for our lights and our nutrient product.

Cost of sales for the three months ended ~~March~~June 3130, 2021 and 2020 was $~~227~~141,000 and $~~195~~134,000, respectively. Gross profit for the three months ended ~~March~~June 3130, 2021 and 2020 was $~~227~~322,000 and $~~112~~142,000, respectively. As a percentage of revenue, gross profit was 5070% and 3651% for the three months ended ~~March~~June 3130, 2021 and 2020, respectively. The increase in our gross profit was due to our increase in revenue.

Selling, General and Administration Expenses

Selling, general and administrative (SG&A ) expenses for the three months ended ~~March~~June 3130, 2021 and 2020 were $~~266~~303,000 and $~~361~~260,000, respectively, an aincrease ~~decrease~~ of $9543,000, or 2617%. We ~~implemented~~The ~~several~~increase ~~cost~~in ~~reduction~~SG&A ~~initiatives~~expenses ~~leading~~was tofrom ~~decreased~~increased ~~wages and benefits of $21,000 and decreased~~ rent expense ofand ~~$70,000. The~~increased ~~remaining~~employee ~~decrease of $4,000 was across our numerous remaining~~ compensation expense ~~accounts~~.

Research and Development Expenses

Research and Development expenses for the three months ended June 30, 2021 and 2020 were comparable at $25,000 and $25,000, respectively.

Legal Judgment

On September 25, 2018, Matthew Geschke (the “Plaintiff”) filed a breach of contract case against us in the San Diego Superior Court of San Diego, California. The Plaintiff claimed damages for breach of an employment contract when we terminated the Plaintiff’s employment agreement on February 22, 2018. On June 26, 2020, the Plaintiff was awarded a default judgment against us in the amount of $448,000. No similar activity occurred during the current year period.

Other Income and Expenses

Other income for the three months ended June 30, 2021 was $658,000, as compared to other expense of $829,000 for the three months ended June 30, 2020. The change in balance was due to the loss on settlement of trade vendor payables totaling $46,000, the change in the fair value of derivative liability of $1,295,000, and the change in interest expense of $146,000, as compared to the prior year period.

Net Loss

Net income for the three months ended June 30, 2021 was $652,000, as compared to a net loss of $1,420,000 for the three months ended June 30, 2020. The increase in net income was due to the increase in gross profit, the decrease in operating expenses, and the change in other income and expenses as discussed above.

Results of Operations for the six months ended June 30, 2021 compared to the six months ended June 30, 2020.

Revenue and Cost of Goods Sold

Revenue for the six months ended June 30, 2021 and 2020 was $917,000 and $583,000, respectively, an increase of $334,000, or 57%. The increase is due to two factors 1) the company’s initiative to focus direct sales and marketing efforts on its nutrient business and 2) the increase in new markets that are granting new cultivation licenses which resulted in new companies obtaining licenses to legally grow cannabis, which has ultimately resulted in new order for our lights and our nutrient product.

Cost of sales for the six months ended June 30, 2021 and 2020 was $368,000 and $329,000, respectively. Gross profit for the six months ended June 30, 2021 and 2020 was $549,000 and $254,000, respectively. As a percentage of revenue, gross profit was 60% and 44% for the six months ended June 30, 2021 and 2020, respectively. The increase in our gross profit was due to our increase in revenue.

Selling, General and Administration Expenses

Selling, general and administrative expenses for the six months ended June 30, 2021 and 2020 were $569,000 and $621,000, respectively, a decrease of $52,000, or 8%. The decrease was primarily from decreased rent expense of $53,000.

Research and Development (R&D) Expenses

R&D expenses for the ~~three~~six months ended ~~March~~June 3130, 2021 and 2020 were comparable at $2651,000 and $2550,000, respectively.

~~Impairment~~Legal ~~of Right of Use Asset~~Judgment

~~Impairment~~On ofSeptember ~~right~~25, 2018, the Plaintiff filed a breach of ~~use~~contract ~~asset~~case ~~for~~against ~~the~~us ~~three~~in ~~months~~the ~~ended~~San ~~March~~Diego ~~31,~~Superior ~~2020~~Court ~~was~~of ~~$82~~San Diego,~~000~~ California. The InPlaintiff ~~March~~claimed ~~2020,~~damages for breach of an employment contract when we ~~determined~~terminated ~~that~~the ~~our~~Plaintiff’s ~~right~~employment ofagreement ~~use~~on ~~asset~~February ~~was~~22, ~~impaired~~2018. ~~and~~On ~~recorded~~June an26, ~~impairment~~2020, ~~charge~~the ~~accordingly.~~Plaintiff Nowas ~~similar~~awarded ~~activity~~a ~~occurred~~default ~~during~~judgment against us in the ~~current~~amount ~~year~~of ~~period~~$448,000.

Impairment of Right of Use (ROU”) Asset

Impairment of ROU asset for the six months ended June 30, 2020 was $82,000. In March 2020, we determined that our ROU asset was impaired and recorded an impairment charge accordingly. (See Note 4 to the accompanying condensed consolidated financial statements). No similar activity occurred during the prior year period.

Other Income and Expenses

Other ~~income~~expense for the ~~three~~six months ended ~~March~~June 3130, 2021 was $1,~~798~~140,000, as compared to other expense of $12,~~282~~111,000 for the ~~three~~six months ended ~~March~~ 31June 30, 2020. The change in balance was due to the loss on settlement of a trade vendor ~~payable~~payables of $~~106~~60,000, offset by a gain on the ~~settlement~~ settlement of debt of $2,000, ~~both~~and reduced financing costs of $15,000, all of three of which did not exist during the prior year period. Additionally, we realized the change in the fair value of derivative liability of $~~495~~800,000, and the change in interest expense of $68214,000, as compared to the prior year period.

Net Loss

Net loss for the ~~three~~six months ended ~~March~~June 3130, 2021 and 2020 was $1,~~863~~211,000 and $13,~~638~~058,000, respectively. The ~~increase~~decrease in net loss was due to to the increase in gross profit, the decrease in operating expenses, and the change in other income and expenses as discussed above.

Liquidity and Capital Resources

Cash and Liquidity

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

Cash Flows Used in Operating Activities

During the ~~three~~six months ended ~~March~~June 3130, 2021, we ~~generated~~used cash from operating activities of $1458,000 as compared to cash used in operating activities of $13111,000 in the prior year period. During the ~~three~~six months ended ~~March~~June 3130, 2021, cash was primarily used to fund our operating loss of of $655,000, a change in the fair value of derivative liabilities of $1725,~~437,~~000, amortization on convertible notes payable of $~~183~~208,000, a change in inventory of $1954,000, a $59118,000 increase in interest due to related parties, $3265,000 of stock-based related compensation, a $5846,000 increase in accounts receivable, and a $~~106~~60,000 loss on settlement of trade accounts ~~payable~~payables.

Cash Flows Used in Investing Activities

During the ~~three~~six months ended ~~March~~June 3130, 2021 and 2020, we used $32,000 and $0 in cash from investing activities to purchase property and equipment.

2021

Cash Flows Provided by (Used in) Financing Activities

During the ~~three~~six months ended ~~March~~June 3130, 2021, we used cash in financing activities of $9,000, compared to cash provided by financing activities of $~~102~~454,000 for the ~~three~~six months ended ~~March~~June 3130, 2020. During the ~~three~~six months ended ~~March~~June 3130, 2021, we made $9,000 of payments on our ~~notes~~ notes payable. During the ~~three~~six months ended ~~March~~June 3130, 2020, we received proceeds of $125,000, net of fees of $25,000, from a secured ~~convertible~~ convertible note payable, $355,000 from loans payable, offset by $2326,000 of payments on our notes payable to related parties.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the ~~three~~six months ended ~~March~~June 3130, 2021, the Company incurred a net loss of $1,~~863~~211,000 and had a shareholders’ ~~deficit~~ deficit of $109,~~376~~691,000 as of ~~March~~June 3130, 2021. In addition, $23,~~915~~065,000 of notes payable to related parties, $~~590~~649,000 of accrued interest to related parties, and $~~820~~824,000 of contract obligations are past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Historically, we have financed our operations primarily through private sales of common stock, a line of credit, loans from a third-party financial institutions, related parties, and operations. We anticipate that our primary capital source will be from the issuance of notes payable or the proceeds from the sale of our common stock. If our sales goals do not materialize as planned, we believe that we can reduce our operating costs and achieve positive cash flow from operations. However, we may not generate sufficient revenues from product sales in the future to achieve profitable operations. If we are not able to achieve profitable operations at some point in the future, we may have insufficient working capital to maintain our operations as we presently intend to conduct them or to fund our expansion, marketing, and product development plans. There can be no assurance that we will be able to obtain such financing on acceptable terms, or at all.

Notes Payable to Related Parties

On May 9, 2016, we entered into note payable agreements with Alan Lien and Alvin Hao, former officers and directors, to borrow $300,000 under each individual note. Pursuant to the terms of each of these agreements, we borrowed $300,000 from each of Alan Lien and Alvin Hao. The notes accrue interest at a rate of 8% per annum, are unsecured and were due on or before May 31, 2018. The notes are currently past due. A total of $600,000 was due on the combined notes at ~~March~~June 3130, 2021 and December 31, 2020.

On May 8, 2019, we entered into a note agreement with the sister of Alvin Hao, a former officer and director, to borrow $150,000. The loan accrues interest at 8% per annum, are unsecured and due on November 8, 2019. The note is currently past due. A total of $150,000 was due on the note at ~~March~~June 3130, 2021 and December 31, 2020.

We entered into note agreements with the parents of Alan Lien, a former officer and director. The loans accrue interest at 10% per annum, are unsecured and were due on or before December 31, 2016. The notes are currently past due.

A total of $40,000 was due on the loans at ~~each~~June ~~of March 31~~30, 2021 and December 20, 2020.

Secured Convertible Notes Payable

On May 10, 2018, we issued a secured debenture (the “2018 Note”) to YA II PN in the principal amount of $1,500,000 with interest at 8% per annum (18% on default) and due on February 9, 2019. The 2018 Note was amended effective February 9, 2019 for which the maturity date was extended to August 9, 2019 and could be converted into our common stock at a conversion price of $0.50 a share. On October 29, 2019, the 2018 Note was further amended to include an extended maturity date of June 30, 2020, and provide a conversion right, in which the principal amount of the 2018 Note, together with any accrued but unpaid interest, could be converted into our common stock at a conversion price at 75% of the lowest volume weighted average price (VWAP) of our common stock during the 10 trading days immediately preceding the conversion date.

2122

On October 29, 2019, we issued a convertible secured debenture (the “2019 Note”) to YA II PN in the principal amount of $275,000 with interest at 10% per annum (15% on default) and due on April 29, 2020. We received net proceeds of $237,500, net of closing costs of $37,500. The 2019 Note provides a conversion right, in which the principal amount of the Note, together with any accrued but unpaid interest, could be converted into our common stock at a conversion price at 75% of the lowest volume weighted average price (VWAP) of our common stock during the 10 trading days immediately preceding the conversion date.

On February 13, 2020, we issued a secured convertible debenture (the “2020 Note”) in the amount of $150,000. The 2020 Note bears interest at a rate of 10% per annum (15% on default) and has a maturity date of August 10, 2021. The 2020 Note is secured by all our and our subsidiaries assets. The 2020 Note provides a conversion right, in which any portion of the principal amount of the 2020 Note, together with any accrued but unpaid interest, may be converted into our common stock at a conversion price equal to 75% of the lowest VWAP of our common stock during the ten (10) trading days immediately preceding the date of conversion, subject to adjustment.

On September 23, 2020, we issued a secured convertible debenture (the “September 2020 Note”) in the amount of $~~150~~350,000. The September 2020 Note bears interest at a rate of 10% per annum (15% on default) and has a maturity date of August 10, 2021. The September 2020 Note is secured by all our and our subsidiaries assets. The 2020 September Note provides a conversion right, in which any portion of the principal amount of the 2020 September Note, together with any accrued but unpaid interest, may be converted into our common stock at a conversion price equal to 75% of the lowest VWAP of our common stock during the ten (10) trading days immediately preceding the date of conversion, subject to adjustment.

Term Loan

On May 7, 2020, the Company was granted a loan (the “PPP loan”) from Wells Fargo Bank in the aggregate amount of $205,000, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act. The PPP loan agreement is dated May 8, 2020, matures on May 7, 2022, bears interest at a rate of 1% per annum, with the first six months of interest deferred, and is unsecured and guaranteed by the U.S. Small Business Administration (“SBA”). The loan term may be extended to May 7, 2025, if mutually agreed to by the Company and lender. A total of $205,000 was due on the loan as of ~~December~~June 3130, ~~2020~~2021.

On June 7, 2020, the Company obtained an Economic Injury Disaster Loan from the SBA in the amount of $150,000. Interest on the loan is at the rate of 3.75% per year, and all loan payments are deferred for twelve months, at which time the balance is payable in monthly installments of $731 over a 30-year term. The loan is secured by all the Company’s assets. A total of $150,000 was due on the loan as of ~~December~~June 3130, ~~2020~~2021.

Critical Accounting Policies

The Securities and Exchange Commission (“SEC”) defines “critical accounting policies” as those that require application of management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Not all of the accounting policies require management to make difficult, subjective or complex judgments or estimates. However, the following policies could be deemed to be critical within the SEC definition.

~~Allowance~~Revenue ~~for Doubtful Accounts~~Recognition

The ~~allowance~~Company ~~for~~recognizes ~~doubtful~~revenue ~~accounts~~in isaccordance ~~based~~with onFinancial ~~our~~Accounting ~~assessment~~Standards ofBoard ~~the~~(“FASB”) ~~collectability~~Accounting ofStandard ~~customer~~Codification (“ASC”) ~~accounts~~606, Revenue from Contracts with Customers (“ASC 606”). WeUnder ~~regularly~~this ~~review~~guidance, ~~the~~revenue ~~allowance~~is recognized when bycontrol ~~considering~~of ~~factors~~promised ~~such~~goods asor ~~historical~~services ~~experience,~~is transferred to the ~~age~~Company’s ofcustomers, ~~the~~in ~~accounts~~an ~~receivable~~amount ~~balances,~~that ~~credit~~reflects ~~quality,~~the ~~economic~~consideration ~~conditions~~the ~~that~~Company ~~may~~expects ~~affect~~to abe ~~customer’s~~entitled ~~ability~~to in exchange for those goods or services. The Company reviews its sales transactions to ~~pay~~identify contractual rights, performance obligations, and ~~expected~~transaction ~~default~~prices, ~~frequency~~including ~~rates~~the allocation of prices to separate performance obligations, if applicable. Revenue ~~Trade~~and ~~receivables~~cost of sales are ~~written~~recognized ~~off~~once atproducts are delivered to the ~~point when~~customer’s ~~they~~control ~~are~~and ~~considered~~performance ~~uncollectible~~obligations are satisfied.

Inventories

We provide inventory reserves based on excess and obsolete inventories determined primarily by future demand forecasts. The write down amount is measured as the difference between the cost of the inventory and market based upon assumptions about future demand and charged to the provision for inventory, which is a component of cost of sales. At the point of the loss recognition, a new, lower cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.

Recent Accounting Pronouncements

See Note 2 of the condensed consolidated financial statements for management’s discussion of recent accounting pronouncements.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not required under Regulation S-K for “smaller reporting companies.”

Item 4. Controls and Procedures.

Management’s evaluation of disclosure controls and procedures.

Our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act as of ~~March~~June 3130, 2021. Based on this evaluation, our principal executive officer and our principal ~~financial~~ financial officer concluded that as of ~~March~~June 3130, 2021, ~~2021,~~ our disclosure controls and procedures were not effective to provide reasonable ~~assurance~~ assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, ~~summarized~~ summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. The conclusion that our disclosure controls and procedures were not effective was due to the presence of material weaknesses in internal control over financial reporting, as that term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. In light of the material weaknesses identified by management, we performed additional analyses and procedures in order to conclude that our financial statements for the year ended December 31, 2020, are fairly presented, in all material respects, in accordance with U.S. generally accepted accounting principles.

Management’s report on internal control over financial reporting.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term as defined in Exchange Act Rule 13a-15(f). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

As of ~~March~~June 3130, 2021, our management assessed the effectiveness of our internal control over financial reporting using the criteria set ~~forth~~ forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013 Framework). Based on this assessment, our management concluded that, as of ~~March~~June 3130, 2021, our internal control over financial reporting was ~~not~~ not effective as of ~~March~~June 3130, 2021 and identified the material weaknesses described below.

Description of Material Weaknesses and Management’s Remediation Initiatives

The following material weaknesses in our internal control over financial reporting were identified by management as of ~~March~~June 3130, 2021:

Ineffective control environment. The Company did not maintain an effective control environment, which is the foundation necessary for effective internal control over financial reporting. Specifically, the Company (i) did not maintain a functioning independent audit committee; (ii) did not have its Board of Directors review and approve significant transactions; (iii) had an insufficient number of personnel appropriately qualified to perform control design, execution and monitoring activities; (iv) had an insufficient number of personnel with an appropriate level of U.S. GAAP knowledge and experience and ongoing training in the application of U.S. GAAP and SEC disclosure requirements commensurate with the Company’s financial reporting requirements; (v) had inadequate segregation of duties consistent with control objectives; and (vi) lack of written documentation of the Company’s key internal control policies and procedures over financial reporting. The Company is required under Section 404 of the Sarbanes-Oxley Act to have written documentation of key internal controls over financial reporting. The Company did not formally document policies and controls to enable management and other personnel to understand and carry out their internal control responsibilities including the lack of closing checklists, budget-to-actual analyses, balance sheet variation analysis, and pro-forma financial statements. Additionally, the Company did not have an adequate process in place to complete its testing and assessment of the design and operating effectiveness of internal control over financial reporting in a timely manner;

Ineffective controls over financial statement close and reporting process. The Company did not maintain effective controls over its financial statement close and reporting process. Specifically, the Company: (i) had insufficient preparation and review procedures for disclosures accompanying the Company’s financial statements; and (ii) did not provide reasonable assurance that accounts were complete and accurate and agreed to detailed support and that reconciliations of accounts were properly performed, reviewed and approved; and

Insufficient segregation of duties in our finance and accounting functions due to limited personnel. We do not have sufficient segregation of duties within accounting functions. During the period ended ~~March~~June 3130, 2021, we had limited personnel that performed nearly all aspects of our financial reporting process, including, but not limited to, access to the underlying accounting records and systems, the ability to post and record journal entries and responsibility for the preparation of the financial statements. Due to the fact that these duties were often performed by the same person, this creates a lack of review over the financial reporting process that would likely result in a failure to detect errors in spreadsheets, calculations, or assumptions used to compile the financial statements and related disclosures as filed with the SEC. These control deficiencies could result in a material misstatement to our interim or annual financial statements that would not be prevented or detected.

As of the date of this report, our remediation efforts continue related to each of the material weaknesses that we have identified in our internal control over financial reporting, and additional time and resources will be required in order to fully address these material weaknesses. We have not been able to complete all actions necessary and test the remediated controls in a manner that would enable us to conclude that such controls are effective. We are committed to implementing the necessary controls to remediate the material weaknesses described below as our resources permit. These material weaknesses will not be considered remediated until (1) the new processes are designed, appropriately controlled and implemented for a sufficient period of time and (2) we have sufficient evidence that the new processes and related controls are operating effectively.

This annual report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our independent registered public accounting firm pursuant to the rules of the SEC that permit us to provide only management’s report in this annual report.

Changes in internal control over financial reporting.

There were no changes in our internal control over financial reporting that occurred during the quarter ended ~~March~~June 3130, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

2425

PART II

Item 1. Legal Proceedings.

Information regarding reportable legal proceedings is contained in Part I, Item 3, “Legal Proceedings,” in our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to the legal proceedings previously disclosed in the Annual Report on Form 10-K, which are incorporated by reference herein.

Item 1A. Risk Factors.

Not required under Regulation S-K for “smaller reporting companies.”

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On March 30, 2021, the Company issued a vendor a cashless five year warrant to purchase four million (4,000,000) shares of common stock of the Company at an exercise price per share equal to $0.001 per share as part of a settlement agreement.

During the ~~three~~six months ended ~~March~~June 3130, 2021, the Company issued its Chief Executive Officer a total of ~~260~~706,~~417~~846 stock options at an exercise ~~price~~ price of $0.~~048~~035 per share.

During the ~~three~~six months ended ~~March~~June 3130, 2021, the Company issued an aggregate of ~~472~~1,~~000~~052,423 shares of common stock pursuant to the compensation agreements with its directors.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

Exhibit Number		Description of Exhibit
31.1		Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101		The following materials from Generation Alpha, Inc.’s Quarterly Report on Form 10-Q for the ~~quarter~~period ended ~~March~~June 3130, 2021, formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Stockholders’ Equity, (iv) the Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Unaudited Condensed Consolidated Financial Statements.

2526

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	GENERATION ALPHA, INC.
Date: May 17, 2021	By:	/s/ Tiffany Davis
Date: August 12, 2021	By:	/s/ Tiffany Davis
		Tiffany Davis
		Chief Executive Officer and Chief Financial Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)

2627

Filing Compare · Generation Alpha, Inc.